<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding - Bofill Rodriguez, M - 2021 | Cochrane Library</title> <meta content="Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding - Bofill Rodriguez, M - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000329.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding - Bofill Rodriguez, M - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000329.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000329.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding" name="citation_title"/> <meta content="Magdalena Bofill Rodriguez" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Anne Lethaby" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="a.lethaby@auckland.ac.nz" name="citation_author_email"/> <meta content="Rosalie J Fergusson" name="citation_author"/> <meta content="Waitemata District Health Board" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD000329.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/02/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000329.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000329.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000329.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Endometrial Ablation Techniques [adverse effects, *methods]; Endometrium [*surgery]; Hysterectomy [adverse effects, *methods]; Hysteroscopy; Menorrhagia [*surgery]; Minimally Invasive Surgical Procedures; Operative Time; Patient Satisfaction; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000329.pub4&amp;doi=10.1002/14651858.CD000329.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000329\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000329\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","th","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000329.pub4",title:"Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding",firstPublishedDate:"Feb 23, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000329.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000329.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000329.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000329.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000329.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000329.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000329.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000329.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000329.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000329.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3615 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000329.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0138"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0049"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-sec-0132"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/appendices#CD000329-sec-0143"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/table_n/CD000329StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/table_n/CD000329StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#CD000329-cr-0004">Magdalena Bofill Rodriguez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#CD000329-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Anne Lethaby</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information#CD000329-cr-0006">Rosalie J Fergusson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information/en#CD000329-sec-0153">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 February 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000329.pub4">https://doi.org/10.1002/14651858.CD000329.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000329-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000329-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000329-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000329-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000329-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD000329-abs-0004">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000329-abs-0001" lang="en"> <section id="CD000329-sec-0001"> <h3 class="title" id="CD000329-sec-0001">Background</h3> <p>Heavy menstrual bleeding (HMB) is common in otherwise healthy women of reproductive age, and can affect physical health and quality of life. Surgery is usually a second‐line treatment of HMB. Endometrial resection/ablation (EA/ER) to remove or ablate the endometrium is less invasive than hysterectomy. Hysterectomy is the definitive treatment and can be via open (laparotomy) approach, or via minimally invasive approaches (vaginally or laparoscopically). Each approach has its own advantages and risk profile. </p> </section> <section id="CD000329-sec-0002"> <h3 class="title" id="CD000329-sec-0002">Objectives</h3> <p>To compare the effectiveness, acceptability and safety of endometrial resection or ablation versus different routes of hysterectomy (open, minimally invasive hysterectomy, or unspecified route) for the treatment of HMB. </p> </section> <section id="CD000329-sec-0003"> <h3 class="title" id="CD000329-sec-0003">Search methods</h3> <p>We searched the Cochrane Gynaecology and Fertility specialised register, CENTRAL, MEDLINE, Embase and PsycINFO (July 2020), and reference lists, grey literature and trial registers. </p> </section> <section id="CD000329-sec-0004"> <h3 class="title" id="CD000329-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) that compared techniques of endometrial resection/ablation with hysterectomy (by any technique) for the treatment of HMB in premenopausal women. </p> </section> <section id="CD000329-sec-0005"> <h3 class="title" id="CD000329-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD000329-sec-0006"> <h3 class="title" id="CD000329-sec-0006">Main results</h3> <p>We included 10 RCTs (1966 participants) comparing EA/ER to hysterectomy (open (abdominal), minimally invasive (laparoscopic or vaginal), or unspecified (or at surgeon's discretion) route of hysterectomy). The results were rated as moderate‐, low‐ and very low‐certainty evidence. </p> <p><i>Endometrial resection/ablation versus open hysterectomy</i> </p> <p>We found two trials. Women having EA/ER are probably less likely to perceive an improvement in HMB compared to women having open hysterectomy (risk ratio (RR) 0.90, 95% confidence interval (CI) 0.84 to 0.95; 2 studies, 247 women; moderate‐certainty evidence) and probably have a 13% risk of requiring further surgery for treatment failure (compared to 0 on the open hysterectomy group; 2 studies, 247 women; moderate‐certainty evidence). Both treatments probably lead to similar quality of life at two years (mean difference (MD) –5.30, 95% CI –11.90 to 1.30; 1 study, 155 women; moderate‐certainty evidence) and satisfaction rate at one year (RR 0.91, 95% CI 0.82 to 1.00; 1 study, 194 women; moderate‐certainty evidence). There may be no difference in serious adverse events (RR 1.29, 95% CI 0.32 to 5.20; 2 studies, 247 women; low‐certainty evidence). EA/ER probably reduces time to return to normal activity compared to open hysterectomy (MD –21.00 days, 95% CI –24.78 to –17.22; 1 study, 197 women; moderate‐certainty evidence). </p> <p><i>Endometrial resection/ablation versus minimally invasive hysterectomy</i> </p> <p>We found five trials. The proportion of women with perception of improvement in HMB at two years may be similar between groups (RR 0.97, 95% CI 0.90 to 1.04; 1 study, 79 women; low‐certainty evidence). Blood loss may be higher in the EA/ER group when assessed using the Pictorial Blood Assessment Chart (MD 44.00, 95% CI 36.09 to 51.91; 1 study, 68 women; low‐certainty evidence). Quality of life is probably lower in the EA/ER group compared to the minimally invasive hysterectomy group at two years according to the 36‐item Short Form (SF‐36) (MD –10.71, 95% CI –15.11 to –6.30; 2 studies, 145 women; moderate‐certainty evidence) and Menorrhagia Multi‐Attribute Scale (RR 0.82, 95% CI 0.70 to 0.95; 1 study, 616 women; moderate‐certainty evidence). EA/ER probably increases the risk of further surgery for HMB compared to minimally invasive hysterectomy (RR 7.70, 95% CI 2.54 to 23.32; 4 studies, 922 women; moderate‐certainty evidence) and treatments probably have similar rates of any serious adverse events (RR 0.75, 95% CI 0.35 to 1.59; 4 studies, 809 women; moderate‐certainty evidence). Women with EA/ER are probably less likely to be satisfied with treatment at one year (RR 0.90, 95% CI 0.85 to 0.94; 1 study, 558 women; moderate‐certainty evidence). We were unable to pool data for time to return to work or normal life because of extreme heterogeneity (99%); however, the three studies reporting this all had the same direction of effect favouring EA/ER. </p> <p><i>Endometrial resection/ablation versus unspecified route of hysterectomy</i> </p> <p>We found three trials. EA/ER may lead to a lower perception of improvement in HMB compared to unspecified route of hysterectomy (RR 0.89, 95% CI 0.83 to 0.95; 2 studies, 403 women; low‐certainty evidence). Although EA/ER may lead to similar quality of life using the SF‐36 General Health Perception at two years' follow‐up (MD –1.90, 95% CI –8.67 to 4.87; 1 study, 209 women; low‐certainty evidence), the proportion of women with improvement in general health at one year may be lower (RR 0.85, 95% CI 0.77 to 0.95; 1 study, 185 women; low‐certainty evidence). EA/ER probably has a risk of 5.4% of requiring further surgery for treatment failure (compared to 0 with total hysterectomy; 2 studies, 374 women; moderate‐certainty evidence) and reduces the proportion of women with any serious adverse event (RR 0.21, 95% CI 0.06 to 0.80; 2 studies, 374 women; moderate‐certainty evidence). Both treatments probably lead to a similar satisfaction rate at one year' follow‐up (RR 0.96, 95% CI 0.88 to 1.04; 3 studies, 545 women; moderate‐certainty evidence). EA/ER may lead to shorter time to return to normal activity (MD –18.90 days, 95% CI –24.63 to –13.17; 1 study, 172 women; low‐certainty evidence). </p> </section> <section id="CD000329-sec-0007"> <h3 class="title" id="CD000329-sec-0007">Authors' conclusions</h3> <p>Endometrial resection/ablation (EA/ER) offers an alternative to hysterectomy as a surgical treatment for HMB. </p> <p>Effectiveness varies with EA/ER compared to different hysterectomy approaches. The perception of improvement in HMB with EA/ER is probably lower compared to open and unspecified route of hysterectomy, but may be similar compared to minimally invasive. Quality of life with EA/ER is probably similar to open and unspecified route of hysterectomy, but lower compared to minimally invasive hysterectomy. Further surgery for treatment failure is probably more likely with EA/ER compared to all routes of hysterectomy. </p> <p>Satisfaction rates also vary. EA/ER probably has a similar rate of satisfaction compared to open and unspecified route of hysterectomy, but a lower rate of satisfaction compared to minimally invasive hysterectomy. The proportion having any serious adverse event appears similar in all groups, but specific adverse events did reported difference between EA/ER and different routes. We were unable to draw conclusions about the time to return to normal activity, but the direction of effect suggests it is likely to be shorter with EA/ER. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000329-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000329-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000329-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000329-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000329-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000329-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000329-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000329-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD000329-abs-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000329-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000329-abs-0002" lang="en"> <h3>Is endometrial resection or ablation more effective, safer or more acceptable than different routes of hysterectomy? </h3> <p><b>Review question</b> </p> <p>This review compares the effectiveness, safety and acceptability of endometrial resection or ablation (EA/ER) compared to different routes of hysterectomy for the treatment of heavy menstrual bleeding (HMB). </p> <p><b>Background</b> </p> <p>Surgical treatments for HMB include: endometrial resection or ablation (removal or destruction of the endometrium (inside lining) of the uterus (womb)) and hysterectomy (surgical removal of the uterus). Hysterectomy can be performed by different routes: by a surgical cut to the abdomen (open), by a minimally invasive procedure that can be by the vagina, or by laparoscopy (a 'keyhole' operation that involves very small surgical cuts to the abdomen). Hysterectomy is effective in permanently stopping HMB, but it halts fertility and is associated with the risks of major surgery, including infection and blood loss. Endometrial resection/ablation is performed by the vagina and cervix (entrance to the uterus). </p> <p><b>Search date</b> </p> <p>In July 2020, we searched for studies that compared endometrial resection/ablation versus hysterectomy for the treatment of HMB. We included 10 studies involving 1966 women<b>.</b> </p> <p><b>Study characteristics</b> </p> <p>We included only randomised controlled trials (RCTs; clinical studies where people are randomly put into one of two or more treatment groups) comparing endometrial ablation or resection and hysterectomy as treatment for HMB. The studies excluded women who had gone through the menopause or had cancer (or precancer) of the uterus. </p> <p><b>Key results and conclusions</b> </p> <p>Women having EA/ER are probably less likely to perceive an improvement in HMB and more likely to require surgery for treatment failure compared to women having open hysterectomy. They probably have a similar quality of life and satisfaction rates, and may also have similar proportions of serious side effects. Some uncommon but important complications, such as infection and bleeding, are more common during open hysterectomy than with EA/ER. </p> <p>Women having EA/ER may have a similar rate of perceiving HMB improvement, but may be less likely to have an objective decrease in blood loss, compared to women having minimally invasive hysterectomy. The EA/ER group probably have a lower quality of life and satisfaction rate. The rate of serious side effects is probably similar but women having EA/ER are probably at increased risk of surgery for treatment failure when compared to minimally invasive hysterectomy. The time taken for women to return to normal activity was shorter with EA/ER than with minimally invasive hysterectomy. </p> <p>Women having EA/ER may be less likely to perceive an improvement in HMB and an improvement in general health compared to women having an unspecified route of hysterectomy (or at surgeon's discretion). EA/ER probably increases the chances of having surgery for treatment failure, but decreases the chances of any serious side effects and has shorter time to return to normal activity if compared to the unspecified route of hysterectomy. </p> <p><b>Identifying harms</b> </p> <p>Both surgical treatments are generally safe, with low complication rates. There is no clear evidence of a difference on the total number of serious side effects between both surgical techniques. However, open hysterectomy and unspecified route of hysterectomy were both associated with a higher chance of individual complications such as infection and bleeding, whereas there was no difference in these outcomes when EA/ER was compared against minimally invasive hysterectomy. </p> <p><b>Quality of the evidence</b> </p> <p>Evidence reported in this review ranged from very low to moderate quality, which suggests that further research may change the result. However, although most of the evidence is moderate, we do not think this will change with further studies. It is moderate because of high risk of differences between groups in the care provided, and in this case, blinding is not feasible due to the nature of the procedures. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000329-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000329-sec-0138"></div> <h3 class="title" id="CD000329-sec-0139">Implications for practice</h3> <section id="CD000329-sec-0139"> <p> <ul id="CD000329-list-0034"> <li> <p>Although hysterectomy is more effective at resolving bleeding problems and satisfaction rates are higher, endometrial destruction by ablation is an alternative to hysterectomy that could be offered to women with heavy menstrual bleeding. </p> </li> <li> <p>Ablation techniques have high satisfaction rates, even though lower than hysterectomy at one and two years' follow‐up, with shorter operation time and hospital stay and earlier recovery. The shorter recovery varies according to the route of the hysterectomy. There was no difference in serious complications between procedures. Some complications were more frequent in the hysterectomy group such as sepsis, blood transfusion and haematoma (vault and wound). A preoperative discussion should focus on the possibility of further surgery being necessary for those women who choose endometrial destruction techniques for relief of their heavy menstrual bleeding. </p> </li> <li> <p>The initial cost of endometrial destruction is clearly lower than that of hysterectomy, but because retreatment is often necessary, the cost difference narrows over time. </p> </li> <li> <p>Minimally invasive hysterectomy (vaginal or laparoscopic) represents an improvement on several of the previously described disadvantages of hysterectomy, and some outcomes, such as duration of hospital stay, time to return to work and time to return to normal activities, have become more comparable with those of endometrial ablation. However, it should be noted that laparoscopic hysterectomy may be associated with longer operating time than other modes of hysterectomy and requires specific surgical expertise and equipment. </p> </li> <li> <p>It is recommended that women be encouraged to play an active role in selecting the type of surgery, based on the personal value that they place on the advantages and disadvantages of each surgical approach. </p> </li> </ul> </p> </section> <h3 class="title" id="CD000329-sec-0140">Implications for research</h3> <section id="CD000329-sec-0140"> <p>Additional trials are needed in the following areas.</p> <p> <ul id="CD000329-list-0035"> <li> <p>Comparison of more recent types of hysterectomy (supracervical, vaginal and laparoscopically assisted vaginal) versus EA/ER techniques. One further trial in this category was added in the 2013 update (<a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>); and another at the 2020 update (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>); however, more data are needed to reduce heterogeneity for some outcomes. These trials did not reported data for cost comparisons, and this is likely to be important in making a treatment decision. </p> </li> <li> <p>Comparison of second‐generation ablation methods versus hysterectomy. Evidence suggests that whereas first‐generation ablation methods did not have an impact on hysterectomy rates for heavy menstrual bleeding, second‐generation methods have overtaken first‐generation methods in the UK and are now the most common operation for heavy menstrual bleeding (<a href="./references#CD000329-bbs2-0048" title="ReidPC . Endometrial ablation in England – coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. European Journal of Obstetrics and Gynecology2007;135(2):191-4.">Reid 2007</a>). One further trial in this category was added in the 2013 update (<a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). </p> </li> <li> <p>Trials with follow‐up of four years or longer to adequately assess the cost differential between the two types of surgery and the requirement for further surgical treatment in women randomly assigned to transcervical resection of the endometrium or to endometrial ablation, even though this may cause confusion with the proportion of women going through menopause. </p> </li> <li> <p>Trials that incorporate 'enhanced recovery' programmes. In the future, findings of these trials may reflect shorter hospital stay for women undergoing hysterectomy, and therefore a smaller difference between the two procedures for this particular outcome. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000329-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000329-sec-0008"></div> <div class="table" id="CD000329-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endometrial resection or ablation compared to open hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to open hysterectomy for HMB</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> HMB<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> open hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with open hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effectiveness</b> </p> <p><b>Woman's perception (proportion with improvement in bleeding symptoms)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>900 per 1000<br/>(840 to 950) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b><br/>(0.84 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life SF‐36 at 2 years</b> – <b>general health perception</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (SF‐36, 2 years) general health perception was 74</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.3 lower</b><br/>(11.9 lower to 1.3 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure within 1 year after surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Risk of having additional surgery in the EA group was 12.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The open hysterectomy (total) has no risk of further surgery for HMB (structural 0).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>937 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>853 per 1000<br/>(768 to 937) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b><br/>(0.82 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/>(8 to 127) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.29</b><br/>(0.32 to 5.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to return to normal activity was 28 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 21 days lower</b><br/>(24.78 lower to 17.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>EA:</b> endometrial ablation; <b>HMB:</b> heavy menstrual bleeding; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (performance).<br/><sup>b</sup>Downgraded one level for inconsistency. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000329-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endometrial resection or ablation versus minimally invasive hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to minimally invasive hysterectomy for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> heavy menstrual bleeding<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> minimally invasive hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with minimally invasive hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Effectiveness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion of women with perception of improvement in bleeding symptoms</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>970 per 1000<br/>(900 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b><br/>(0.90 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PBAC score</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PBAC score (continuous data) ‐</p> <p>At 2 years' follow‐up was 29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 44 higher</b><br/>(36.09 higher to 51.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SF‐36 general health perception</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (continuous data) –</p> <p>SF‐36 at 2 years – general health perception was 77.48</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 10.71 lower</b><br/>(15.11 lower to 6.3 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion with MMAS</b> = 100 (best possible) </p> <p>15 months after randomisations</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>583 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>478 per 1000<br/>(408 to 553) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.82</b><br/>(0.70 to 0.95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>616<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure within 1 year after surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(11 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 7.70</b><br/>(2.54 to 23.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>922<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>971 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>874 per 1000<br/>(826 to 913) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b><br/>(0.85 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>558<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/>(13 to 59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b><br/>(0.35 to 1.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>809<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>We were unable to pool data because of extreme heterogeneity (99%).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MMAS:</b> Menorrhagia Multi‐Attribute Scale; <b>PBAC:</b> Pictorial Blood Loss Assessment Chart; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision. One small trial.<br/><sup>b</sup>Downgraded one level for risk of bias (performance). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000329-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to unspecified (or at surgeon's discretion) hysterectomy for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> heavy menstrual bleeding<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> surgeon's choice of route of hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with unspecified (or at surgeon's discretion) hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effectiveness</b> </p> <p><b>Proportion of women with perception of improvement of bleeding symptoms</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>965 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>859 per 1000<br/>(801 to 917) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b><br/>(0.83 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>403<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p><b>SF‐36 general health perception</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (continuous data)</p> <p>– SF‐36 at 1 year –</p> <p>general health perception was 66.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.9 lower</b><br/>(8.67 lower to 4.87 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion with improvement in general health</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>955 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>812 per 1.000<br/>(735 to 907) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b><br/>(0.77 to 0.95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Risk of having additional surgery in the endometrial resection/ablation group was 5.4% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total hysterectomy has no risk of further surgery for treatment failure (structural 0). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>773 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>742 per 1000<br/>(680 to 804) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b><br/>(0.88 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>545<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/>(4 to 47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.21</b><br/>(0.06 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to return to normal activity was 32 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 18.9 days lower</b><br/>(24.63 lower to 13.17 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (performance).<br/><sup>b</sup>Downgraded one level for inconsistency, as it may present substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000329-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000329-sec-0009"></div> <section id="CD000329-sec-0010"> <h3 class="title" id="CD000329-sec-0010">Description of the condition</h3> <p>Heavy menstrual bleeding (HMB) is excessive blood loss that interferes with women's quality of life, either physical, psychological, material, or social (<a href="./references#CD000329-bbs2-0042" title="MunroMG , CritchleyHO , BroderMS , FraserIS . FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynaecology and Obstetrics2011;113(1):3-13.">Munro 2011</a>; <a href="./references#CD000329-bbs2-0046" title="NICE guideline. Heavy menstrual bleeding: assessment and management. www.nice.org.uk/guidance/ng88 (accessed prior to 21 January 2020).">NICE 2018</a>). Many other terms are used as HMB synonyms, including menorrhagia, abnormal menstrual bleeding, abnormal uterine bleeding and disordered uterine bleeding. These terms have not always been universally defined, and there is considerable overlap and confusion between them in the existing literature (<a href="./references#CD000329-bbs2-0057" title="WoolcockJG , CritchleyHO , MunroMG , BroderMS , FraserIS . Review of the confusion in current and historical terminology and definitions for disturbances in menstrual bleeding. Fertility and Sterility2008;90(6):2269.">Woolcock 2008</a>). In response to this confusion, the International Federation of Gynaecology and Obstetrics (FIGO) formally defined HMB as "the woman's perspective of increased menstrual volume, regardless of regularity, frequency, or duration" (<a href="./references#CD000329-bbs2-0042" title="MunroMG , CritchleyHO , BroderMS , FraserIS . FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynaecology and Obstetrics2011;113(1):3-13.">Munro 2011</a>). </p> <p>HMB is a common presenting complaint for primary care services and a frequent reason for secondary referral, with 5% of women between 30 and 49 years of age seeking medical attention for the problem (<a href="./references#CD000329-bbs2-0023" title="CooperK , LeeA , ChienP , RajaE , TimmarajuV , BhattacharyaS . Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. British Journal of Obstetrics and Gynaecology2011;118(10):1171-9.">Cooper 2011</a>; <a href="./references#CD000329-bbs2-0055" title="VesseyM , Villard-MackintoshL , McPhersonK , CoulterA , YeatesD . The epidemiology of hysterectomy: findings in a large cohort study. British Journal of Obstetrics and Gynaecology1992;99(5):402-7.">Vessey 1992</a>). </p> <p>Personal perception is often what determines the need for treatment and assessment of outcomes afterwards.  </p> <p>Intervention for HMB should be aimed at correction of identified underlying causes, control of bleeding, amelioration of anaemia and improvement in quality‐of‐life measures, with the woman's contraceptive requirements or desire for future fertility considered, along with individual preferences for treatment.  </p> </section> <section id="CD000329-sec-0011"> <h3 class="title" id="CD000329-sec-0011">Description of the intervention</h3> <p>Many well‐established treatment options for HMB are available, including hormonal and non‐hormonal medications, but, among women who do not desire future fertility or for whom medical treatment may be problematic, inconvenient or prolonged, surgical management may be preferred.  </p> <p>Until the mid‐1980s, hysterectomy was the only option for such women and 60% of women presenting with HMB during this time underwent hysterectomy as a first‐line treatment (<a href="./references#CD000329-bbs2-0045" title="National Collaborating Centre for Women's and Children's Health. Heavy Menstrual Bleeding. London: RCOG Press, 2007.">NICE 2007</a>). Hysterectomy can be performed via the open (laparotomy) approach, or via minimally invasive approaches such as vaginally or laparoscopically (including robotic surgery). </p> <p>There are considerable differences between types of approach with regard to intraoperative and postoperative complications, duration of surgery, duration of hospital stay, duration of recovery and cost. In earlier versions of the review, we pooled the results for hysterectomy by all approaches, and, in the 2020 version of the review, we separated the comparisons into open hysterectomy versus endometrial resection/ablation and minimally invasive hysterectomy (vaginal and laparoscopic) versus endometrial resection/ablation. </p> <p>Endometrial ablation or resection (EA/ER) are minimally invasive hysteroscopic surgical interventions for HMB involving the destruction (ablation) or removal (resection) of the endometrium. Since it was introduced in the 1990s, its popularity as an alternative to hysterectomy has grown (<a href="./references#CD000329-bbs2-0027" title="FernandezH . Update on the management of menometrorrhagia: new surgical approaches. Gynecological Endocrinology2011;Suppl 1:1131-6.">Fernandez 2011</a>). An examination of the UK National Health Service (NHS) statistics in 2005 revealed that endometrial destruction was being performed more frequently than hysterectomy for benign HMB in the UK (<a href="./references#CD000329-bbs2-0048" title="ReidPC . Endometrial ablation in England – coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. European Journal of Obstetrics and Gynecology2007;135(2):191-4.">Reid 2007</a>). The trend seems to continue over time. A UK National HMB audit in 2019 reported that 40% of the women referred for HMB received surgery during the first year after their first outpatient clinic visit, with 57.8% receiving endometrial ablation and 37. 2% receiving hysterectomy (<a href="./references#CD000329-bbs2-0031" title="GearyR , Gurol-UrganciI , KiranA , Cromwell D Bansi-Matharu L, Shakespeare J et al. Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit. BMJ2019;9(2):e024260. [DOI: 10.1136/bmjopen-2018-024260]">Geary 2019</a>). In one long‐term study with up to 25 years' follow‐up in the UK, only 25% of the woman with an endometrial resection or ablation underwent a subsequent hysterectomy; and 75% of the surgeries were in the first five years of follow‐up (<a href="./references#CD000329-bbs2-0036" title="KalampokasE , McRobbieS , PayneF , ParkinDE . Long-term incidence of hysterectomy following endometrial resection or endometrial ablation for heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2017;139(1):61-4. [DOI: 10.1002/ijgo.12259]">Kalampokas 2017</a>), suggesting EA/ER may have a role in limiting the number of hysterectomies performed. However, this may also reflect progression through menopause for many of these women. </p> <p>Endometrial resection/ablation techniques are classically divided, according to the requirement of hysteroscopy to perform the ablation, in first‐ and second‐generation techniques. First‐generation techniques require direct hysteroscopic vision throughout the procedure and include desiccation of the endometrium by way of rollerball endometrial ablation (REA) and transcervical resection of the endometrium (TCRE) with loop electrode. This can be useful to identify and remove other endometrial pathology such as polyps and fibroids. One potential complication of endometrial resection is systemic fluid overload due to absorption of hysteroscopic fluid; therefore, careful intraoperative input/output fluid balance requires attention and documentation. The efficacy and safety of first‐generation techniques are often operator dependent.  </p> <p>Newer technologies were subsequently introduced; second‐generation techniques are non‐hysteroscopic, considered easier to perform, equally effective and safe (<a href="./references#CD000329-bbs2-0040" title="MadhuCK , NatteyJ , NaeemT . Second generation endometrial ablation techniques: an audit of clinical practice. Archives of Gynecology and Obstetrics2009;280(4):599-602. [DOI: 10.1007/s00404-009-0982-7]">Madhu 2009</a>), reporting lower complication rates of around 1% for bipolar ablation (<a href="./references#CD000329-bbs2-0016" title="AthanatosD , PadosG , VenetisCA , StamatopoulosP , RoussoD , TsolakidisD . Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial. Clinical and Experimental Obstetrics &amp; Gynecology2015;42(3):347-51. [PMID: 26152008]">Athanatos 2015</a>; <a href="./references#CD000329-bbs2-0039" title="LabergeP , LeylandN , MurjiA , FortinC , MartynP , VilosG , et al. Endometrial ablation in the management of abnormal uterine bleeding. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC]2015;37(4):362-79. [PMID: 26001691]">Laberge 2015</a>). All of these techniques, with the exception of hydrothermal ablation and endometrial laser intrauterine thermal therapy, involve performing surgery with a hysteroscope (i.e. without direct visualisation). The second‐generation techniques have allowed widespread use of EA, as they require less‐advanced hysteroscopic skill and do not necessitate intraoperative fluid balance. However, these procedures depend heavily on the surgical equipment itself for efficacy and safety. Newer techniques, sometimes called third generation, differ from the second because they have replaced latex with silicone in the balloon and have active fluid circulation, which enables the total endometrial surface to receive equal heat distribution (<a href="./references#CD000329-bbs2-0038" title="KumarV , ChodankarR , GuptaJK . Endometrial ablation for heavy menstrual bleeding. Women's Health (London, England)2016;12(1):45-52. [DOI: 10.2217/whe.15.86]">Kumar 2016</a>). </p> <p>There are some devices for EA that are currently out of the market for different reasons. Laser EA with the Neodymium was expensive and time consuming, so, although effective, have become obsolete (<a href="./references#CD000329-bbs2-0043" title="MunroM . Endometrial ablation. Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology2018;46:120-39. [DOI: 10.1016/j.bpobgyn.2017.10.003]">Munro 2018</a>). The microwave endometrial ablation (MEA) and the Vesta balloon (radiofrequency ablation via electrodes on the surface of a balloon) were withdrawn from the market for commercial reasons (<a href="./references#CD000329-bbs2-0015" title="ArnoldA , AbbottJ . Endometrial ablation. Obstetrics and Gynaecology Magazine2015;17(4):-. [www.ogmagazine.org.au/17/4-17/endometrial-ablation/]">Arnold 2015</a>). None of these devices were part of the comparisons included in this review. </p> </section> <section id="CD000329-sec-0012"> <h3 class="title" id="CD000329-sec-0012">How the intervention might work</h3> <p>Hysterectomy is regarded as 'definitive' treatment for HMB with guaranteed amenorrhoea and cessation of fertility and little need for future treatment. However, hysterectomy by any route is associated with all the complications of major surgery, including intraoperative bleeding, infection and venous thromboembolism. Other reported complications include urinary incontinence and dyspareunia. Urinary tract injuries are an unusual hysterectomy complication, having an overall incidence in laparoscopic hysterectomy of 0.73% (bladder 0.05% to 0.66%, ureter 0.02% to 0.4%) (<a href="./references#CD000329-bbs2-0014" title="AdelmanMR , BardsleyTR , SharpHT . Urinary tract injuries in laparoscopic hysterectomy: a systematic review. Journal of Minimally Invasive Gynecology2014;21(4):558-66. [DOI: 10.1016/j.jmig.2014.01.006]">Adelman 2014</a>). </p> <p>EA/ER are procedures that destroy (EA) or remove (ER) the endometrium, reducing menstrual bleeding. EA/ER is a less‐invasive surgical option for women with HMB, although a successful outcome after EA/ER is not guaranteed and further surgery is occasionally required (<a href="./references#CD000329-bbs2-0019" title="BourdrezP , BongersMY , MolBW . Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Fertility and Sterility2004;82(1):160-6.">Bourdrez 2004</a>; <a href="./references#CD000329-bbs2-0044" title="NageleF , RubingerT , MagosA . Why do women choose endometrial ablation rather than hysterectomy?Fertility and Sterility1998;69(6):1063-6.">Nagele 1998</a>). Endometrial resection/ablation is often chosen because of perceived shorter hospitalisation, quick return to normal functioning and avoidance of major surgery (<a href="./references#CD000329-bbs2-0044" title="NageleF , RubingerT , MagosA . Why do women choose endometrial ablation rather than hysterectomy?Fertility and Sterility1998;69(6):1063-6.">Nagele 1998</a>). Vaginal discharge and increased period pain are common complications following endometrial resection/ablation. Uncommon complications include intraoperative uterine perforation and associated pelvic organ injury from direct perforation or electrosurgical burns. Pregnancies occurring after EA/ER have been reported to be at higher risk of ectopic pregnancy, preterm birth and abnormality of placentation (<a href="./references#CD000329-bbs2-0052" title="SharpHT . Endometrial ablation: postoperative complications. American Journal of Obstetrics and Gynecology2012;207(4):242-7.">Sharp 2012</a>). </p> </section> <section id="CD000329-sec-0013"> <h3 class="title" id="CD000329-sec-0013">Why it is important to do this review</h3> <p>HMB is a common reason for women to seek treatment and many choose a surgical option as first‐ or second‐line management. Surgical methods for treatment of HMB show a trend in favour of endometrial resection/ablation and towards newer endometrial resection/ablation techniques. In the late 1980s and early 1990s, 60% of women with HMB who were referred to a gynaecologist in the UK were treated with hysterectomy (<a href="./references#CD000329-bbs2-0024" title="CoulterA , BradlowJ , AgassM , Martin-BatesC , TullockA . Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. British Journal of Obstetrics and Gynaecology1991;98(8):789-96.">Coulter 1991</a>), but an examination of NHS statistics in 2005 revealed that endometrial destruction was being performed more frequently than hysterectomy for benign HMB in the UK (<a href="./references#CD000329-bbs2-0048" title="ReidPC . Endometrial ablation in England – coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. European Journal of Obstetrics and Gynecology2007;135(2):191-4.">Reid 2007</a>). </p> <p>Despite this trend, many women still express a preference for first‐line hysterectomy (<a href="./references#CD000329-bbs2-0037" title="KennedyAD , SculpherMJ , CoulterA , DwyerN , ReesM , AbramsKR , et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes and costs. JAMA2002;288(21):2701-8.">Kennedy 2002</a>), and rates of different methods of hysterectomy are evolving.       </p> <p>As surgical techniques for both hysterectomy and endometrial resection/ablation continue to evolve, corresponding changes in success rates, outcomes and complications will be noted, necessitating regular comparison and review.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000329-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000329-sec-0014"></div> <p>To compare the effectiveness, acceptability and safety of endometrial resection or ablation versus different routes of hysterectomy (open, minimally invasive hysterectomy, or unspecified route) for the treatment of HMB. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000329-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000329-sec-0015"></div> <section id="CD000329-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000329-sec-0017"> <h4 class="title">Types of studies</h4> <p>Published and non‐published randomised controlled trials (RCTs) were eligible for inclusion. We excluded quasi‐randomised trials. </p> </section> <section id="CD000329-sec-0018"> <h4 class="title">Types of participants</h4> <section id="CD000329-sec-0019"> <h5 class="title">Source of recruitment</h5> <p>Primary care, family planning and specialist clinics.</p> </section> <section id="CD000329-sec-0020"> <h5 class="title">Inclusion criterion</h5> <p> <ul id="CD000329-list-0001"> <li> <p>Women of reproductive years with HMB (including both heavy regular periods (menorrhagia) and heavy irregular periods (metrorrhagia)), measured objectively or subjectively. </p> </li> </ul> </p> </section> <section id="CD000329-sec-0021"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD000329-list-0002"> <li> <p>Postmenopausal bleeding (more than one year from the last period).</p> </li> <li> <p>HMB caused by uterine malignancy or endometrial hyperplasia.</p> </li> <li> <p>Iatrogenic causes of HMB (e.g. intrauterine coil devices).</p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0022"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD000329-list-0003"> <li> <p>Endometrial resection/ablation (including first‐generation techniques, such as TCRE with loop electrode or rollerball; second‐generation techniques, such as EA by thermal balloon, microwave, thermal free‐fluid, radiofrequency and cryotherapy); and third‐generation EA techniques that are similar to the second‐generation techniques but have replaced latex with silicone in the balloon and have active fluid circulation. </p> </li> <li> <p>Hysterectomy (by abdominal, vaginal and laparoscopic/laparoscopically assisted/robotic routes). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0023"> <h4 class="title">Types of outcome measures</h4> <section id="CD000329-sec-0024"> <h5 class="title">Primary outcomes</h5> <section id="CD000329-sec-0025"> <h6 class="title">Effectiveness (improvement in bleeding)</h6> <p> <ul id="CD000329-list-0004"> <li> <p>Woman's perception (proportion with improvement in bleeding symptoms).</p> </li> <li> <p>Pictorial Blood Loss Assessment Chart (PBAC) score: a visual measure of amount of blood loss (clinically significant HMB correlates with a score greater than 100).* </p> </li> <li> <p>Quality‐of‐life scores (continuous data).</p> </li> <li> <p>Quality of life (proportion with improvement).</p> </li> <li> <p>Requirement for further surgery for treatment failure.</p> </li> </ul> </p> <p>*PBAC score: a score over 100 suggests significantly HMB. A reduction from over 100 to under 100 would be clinically significant at an individual level. </p> </section> <section id="CD000329-sec-0026"> <h6 class="title">Acceptability</h6> <p> <ul id="CD000329-list-0005"> <li> <p>Proportion satisfied with treatment.</p> </li> </ul> </p> </section> <section id="CD000329-sec-0027"> <h6 class="title">Safety (adverse outcomes)</h6> <p> <ul id="CD000329-list-0006"> <li> <p>Any serious adverse events (reported as any serious adverse event or any major complications).</p> </li> <li> <p>Adverse events: short term (intraoperative and immediately postoperative).</p> </li> <li> <p>Adverse events: long term (after hospital discharge).</p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0028"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000329-list-0007"> <li> <p>Duration of surgery.</p> </li> <li> <p>Duration of hospital stay.</p> </li> <li> <p>Time to return to normal activity.</p> </li> <li> <p>Time to return to work.</p> </li> <li> <p>Total health service cost per woman.</p> </li> <li> <p>Total individual cost per woman.</p> </li> </ul> </p> </section> </section> </section> <section id="CD000329-sec-0029"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched all publications that would potentially describe RCTs comparing surgical techniques to resect or ablate the endometrium versus hysterectomy for the treatment of HMB. We consulted with the Cochrane Gynaecology and Fertility Group Information Specialist regarding our search strategies for identifying potential studies for inclusion. </p> <section id="CD000329-sec-0030"> <h4 class="title">Electronic searches</h4> <p>The original search was performed in 1999. Updated searches were performed in 2008, 2013, 2018 and 2020. </p> <p>We searched the following databases:</p> <p> <ul id="CD000329-list-0008"> <li> <p>the Gynaecology and Fertility Group's specialised register, ProCite platform (searched 29 July 2020; <a href="./appendices#CD000329-sec-0144">Appendix 1</a>); </p> </li> <li> <p>CENTRAL via the Cochrane Register of Studies Online (CRSO), Web platform (searched 29 July 2020; <a href="./appendices#CD000329-sec-0145">Appendix 2</a>); </p> </li> <li> <p>MEDLINE, Ovid platform (searched from 1946 to 29 July 2020; <a href="./appendices#CD000329-sec-0146">Appendix 3</a>); </p> </li> <li> <p>Embase, Ovid platform (searched from 1980 to 29 July 2020; <a href="./appendices#CD000329-sec-0147">Appendix 4</a>); </p> </li> <li> <p>PsycINFO, Ovid platform (searched from 1806 to 29 July 2020; <a href="./appendices#CD000329-sec-0148">Appendix 5</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0031"> <h4 class="title">Searching other resources</h4> <p>The principal review author searched the following trial registers for ongoing trials: <a href="http://clinicaltrials.gov/ct2/home" target="_blank">ClinicalTrials.gov</a> (a service of the US National Institutes of Health); and the World Health Organization International Trials Registry Platform search portal (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch/Default.aspx</a>) in July 2020 (<a href="./appendices#CD000329-sec-0149">Appendix 6</a>). </p> <p>We searched reference lists of all studies that appeared to meet the inclusion criteria of the review, other relevant studies and evidence‐based guidelines on the management of abnormal bleeding. We contacted experts in the field regarding additional studies. </p> </section> </section> <section id="CD000329-sec-0032"> <h3 class="title" id="CD000329-sec-0032">Data collection and analysis</h3> <p>We performed statistical analysis in accordance with guidelines described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000329-bbs2-0034" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). When possible, we pooled outcomes statistically. </p> <section id="CD000329-sec-0033"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AL and IC or AL and SS in 2008, RJF and AL in 2013, RJF and MBR in 2018 and 2020) independently selected studies. The final list of included studies reflected consensus between the two review authors. Details of the screening and selection process are shown in <a href="#CD000329-fig-0001">Figure 1</a>. We collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. </p> <div class="figure" id="CD000329-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study screening and selection process (2018 to 2020)." data-id="CD000329-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study screening and selection process (2018 to 2020).</p> </div> </div> </div> </section> <section id="CD000329-sec-0034"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AL and IC in 2008, RJF and AL in 2013, MBR and RJF in 2019 and 2020) independently assessed the characteristics of the included studies using forms designed according to Cochrane guidelines and described in <a href="./references#CD000329-bbs2-0034" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>. </p> <p>When necessary, we sought additional information on trial methodology or original trial data from the principal or corresponding author of any trials that appeared to meet the eligibility criteria (see <a href="#CD000329-sec-0141">Acknowledgements</a> section for details of the study authors who provided clarification of data beyond that reported in the publications). </p> <p>We extracted quality criteria and methodological details from each study as follows.</p> <section id="CD000329-sec-0035"> <h5 class="title">Trial characteristics</h5> <p> <ul id="CD000329-list-0009"> <li> <p>Study design.</p> </li> <li> <p>Numbers of women randomly assigned, excluded and lost to follow‐up.</p> </li> <li> <p>Whether an intention‐to‐treat analysis was done.</p> </li> <li> <p>Whether a power calculation was done.</p> </li> <li> <p>Duration, timing and location of the study.</p> </li> <li> <p>Number of centres.</p> </li> <li> <p>Source of funding.</p> </li> </ul> </p> </section> <section id="CD000329-sec-0036"> <h5 class="title">Characteristics of study participants</h5> <p> <ul id="CD000329-list-0010"> <li> <p>Age and any other recorded characteristics of participants in the study.</p> </li> <li> <p>Inclusion criteria.</p> </li> <li> <p>Exclusion criteria.</p> </li> <li> <p>Type of surgery.</p> </li> <li> <p>Source of participants.</p> </li> <li> <p>Proportion participating of those eligible.</p> </li> </ul> </p> </section> <section id="CD000329-sec-0037"> <h5 class="title">Interventions used</h5> <p> <ul id="CD000329-list-0011"> <li> <p>Type of endometrial destruction technique used and route of hysterectomy performed.</p> </li> </ul> </p> </section> <section id="CD000329-sec-0038"> <h5 class="title">Outcomes</h5> <p> <ul id="CD000329-list-0012"> <li> <p>Methods used to evaluate menstrual symptoms (e.g. PBAC score, woman‐defined 'improvement in symptoms'). </p> </li> <li> <p>Methods used to measure requirement for further surgery for HMB.</p> </li> <li> <p>Methods used to evaluate participant satisfaction and change in quality of life after surgery. </p> </li> <li> <p>Methods used to record adverse surgical events.</p> </li> <li> <p>Methods used to measure resource and individual costs.</p> </li> <li> <p>Methods used to measure duration of surgery, hospital stay and recovery time.</p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0039"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed included trials for risk of bias using the 'Risk of bias tool' developed by Cochrane (<a href="./references#CD000329-bbs2-0034" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). </p> <p> <ul id="CD000329-list-0013"> <li> <p>Sequence generation (whether the allocation sequence was adequately generated to produce comparable groups). </p> </li> <li> <p>Allocation concealment (whether the allocation was adequately concealed).</p> </li> <li> <p>Blinding of participants, personnel and outcome assessors (whether knowledge of the allocated intervention was adequately controlled during the study). </p> </li> <li> <p>Incomplete outcome data (whether incomplete outcome data were adequately addressed).</p> </li> <li> <p>Selective outcome reporting (whether reports of the study were free of the suggestion of selective outcome reporting). </p> </li> <li> <p>Other sources of bias (whether the study was apparently free of other problems that could put it at high risk of bias, e.g. baseline imbalance, bias related to study design, early termination of the study). </p> </li> </ul> </p> <p>Details of the risk of bias for each included study are displayed in the <a href="./references#CD000329-sec-0159" title="">Characteristics of included studies</a> table and are summarised in <a href="#CD000329-fig-0002">Figure 2</a> and <a href="#CD000329-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD000329-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD000329-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000329-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000329-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> </section> <section id="CD000329-sec-0040"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. number of adverse outcomes), we used the numbers of events in the control and intervention groups of each study to calculate risk ratios (RRs). For continuous data (e.g. PBAC score), if all studies reported the same outcomes, we calculated mean differences (MDs) between treatment groups. If studies reported similar outcomes on different scales, we calculated the standardised mean difference (SMD). We reversed the direction of effect of individual studies, if required, to ensure consistency across trials. We treated ordinal data (e.g. quality‐of‐life scores) as continuous data. We presented 95% confidence intervals (CIs) for all outcomes. When data needed to calculate RRs or MDs were not available, we utilised the most detailed numerical data available that facilitated similar analyses of included studies (e.g. test statistics, P values). We compared the magnitude and direction of effect reported by studies versus how they were presented in the review, while taking account of legitimate differences. </p> <p>For dichotomous data (e.g. proportion of participants satisfied with their treatment), we expressed results of each study as an RR. For some dichotomous outcomes (e.g. proportion of participants requiring further surgery), a higher proportion represented a negative consequence of that treatment, and for other outcomes (e.g. proportion with improvement in menstrual blood loss), a higher proportion was considered a benefit of treatment. This approach to the categorising of outcomes should be noted when summary graphs for the meta‐analysis are viewed for assessment of benefits as opposed to harms of treatment. Thus, for some dichotomous outcomes, treatment benefit has been displayed as RRs and CIs to the left of the centre line, but for others, a treatment benefit has been shown to the right of the centre line. Each outcome was labelled for clarification. </p> <p>For other outcomes for which high values were considered a negative consequence of treatment (e.g. duration of surgery, length of hospital stay and time to return to work), evaluation of the summary graphs reveals that means and CIs to the left were considered a benefit of endometrial destruction. </p> <p>With one exception, quality‐of‐life scores were entered as continuous data – mean plus standard deviation (SD) values after treatment. However, one study recorded the percentage mean change of EuroQol scores from baseline to four months after treatment. Some scales measured general quality‐of‐life summary score; others reported results separately in different categories, representing general quality of life but without a summary score; still others used more specific measurements of aspects of quality of life, such as anxiety, social adjustment and depression. </p> <p>For some outcomes, women were assessed at different periods of follow‐up after surgery.</p> <p> <ul id="CD000329-list-0014"> <li> <p>Menstrual symptoms were recorded at one, two, three and four years after surgery, PBAC scores at one and two years after surgery, and quality of life at four months and one, two and four years after treatment. </p> </li> <li> <p>Adverse events were recorded before and after discharge from hospital.</p> </li> <li> <p>Requirement for further surgery was measured separately within the first year and at two, three and four years after treatment. </p> </li> </ul> </p> </section> <section id="CD000329-sec-0041"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the woman with HMB who was randomly assigned to endometrial resection/ablation or hysterectomy. </p> </section> <section id="CD000329-sec-0042"> <h4 class="title">Dealing with missing data</h4> <p>We analysed data on an intention‐to‐treat basis as far as possible; otherwise, we only analysed available data. When we found that data were missing, we attempted to obtain this information from the original trial authors. </p> </section> <section id="CD000329-sec-0043"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity (variations) between the results of different studies by visual inspection of scatter of data points on the graphs and overlap in their CIs. More formally, we examined the results of the I² statistic (a quantity that describes approximately the proportion of variation in point estimates that is due to heterogeneity rather than sampling error; <a href="./references#CD000329-bbs2-0033" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2008;327(7414):557-60.">Higgins 2008</a>). When we found statistical heterogeneity to be very substantial (greater than 90%), we considered calculation of a summary effect measure to be inappropriate and we did not pool study data. Results of these studies can be viewed in forest plots that portray the range of values for comparison in each study. </p> </section> <section id="CD000329-sec-0044"> <h4 class="title">Assessment of reporting biases</h4> <p>We aimed to avoid reporting bias by using a robust search strategy with no restrictions on language or publication forum. We identified multiple publications of the same study for several of the included studies and we referenced them as such. If we had found 10 or more studies to include in the analysis, we planned to use funnel plots to explore the possibility of small‐study effects. </p> </section> <section id="CD000329-sec-0045"> <h4 class="title">Data synthesis</h4> <p>Combination of data was not always possible, as some outcomes were measured differently (e.g. some trials used PBAC score as a measure of improvement in bleeding, while others used proportion reporting improvement in bleeding symptoms, proportion with excessive bleeding, etc.). We displayed such data in the forest plots; however, often only one trial contributed data to each plot. </p> <p>For continuous data (e.g. PBAC score), if all studies reported the same outcomes, we calculated MDs between treatment groups. We displayed continuous outcomes differently according to whether benefit or harm was measured. For most quality‐of‐life scores, a high score represented a benefit of treatment, but for the Hospital Anxiety and Depression Scale (HADS), a high score represented a greater degree of anxiety or depression. To present quality‐of‐life scales that differed in this way on the same graph, we displayed HADS scores as minus values, so that we could include all quality‐of‐life continuous outcomes in a single forest plot. </p> </section> <section id="CD000329-sec-0046"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>A priori, we planned to explore the possible contribution of differences in trial design to any heterogeneity identified in the manner described under <a href="#CD000329-sec-0043">Assessment of heterogeneity</a>. </p> <p>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a meaningful summary. Where meta‐analyses were able to be performed, we checked for heterogeneity by visually inspecting the forest plots for evidence of poor overlap of the 95% CIs. More formally, we used the Chi² test (with a P &lt; 0.10 being evidence of significance) and the I² value. <i>The Cochrane Handbook for Systematic Reviews of Interventions</i> suggested an approximate guide for interpretation of I² values (<a href="./references#CD000329-bbs2-0034" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>): </p> <p> <ul id="CD000329-list-0015"> <li> <p>0% to 40% might not be important;</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100% was considered substantial heterogeneity.</p> </li> </ul> </p> </section> <section id="CD000329-sec-0047"> <h4 class="title">Sensitivity analysis</h4> <p>To assess the robustness of pooled estimates, we conducted the following sensitivity analyses for primary outcomes. </p> <p> <ul id="CD000329-list-0016"> <li> <p>Estimates based on all relevant trials regardless of evidence of allocation concealment versus estimates based on trials that provided clear evidence that allocation was concealed. </p> </li> <li> <p>Estimates based on all relevant trials regardless of missing data and loss to follow‐up versus estimates based on trials in which incomplete outcome assessment was not likely to cause bias. </p> </li> </ul> </p> </section> <section id="CD000329-sec-0048"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We generated 'Summary of findings' tables using GRADEpro software (<a href="./references#CD000329-bbs2-0032" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed prior to 17 July 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a>). These tables evaluate the overall certainty of the body of evidence for the main review outcomes: effectiveness (proportion with perception of improvement in bleeding symptoms, PBAC score, quality of life and requirement for further surgery for treatment failure), acceptability (proportion satisfied with treatment), safety (any serious adverse event) and time to return to normal activity using GRADE criteria. The time to return to normal activity was added on the 2020 update. </p> <p>We justified, documented and incorporated judgements about evidence certainty (high, moderate, low or very low) into reporting of results for each of these outcomes. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000329-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000329-sec-0049"></div> <section id="CD000329-sec-0050"> <h3 class="title">Description of studies</h3> <p>We included 10 RCTs comparing techniques of removal or ablation of endometrium versus hysterectomy by any route for the treatment of HMB. Four trials had multiple publications, each based on the same study population but providing assessment of different outcomes and different follow‐up times, as well as cost‐utility analyses of previously published data (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). We did not consider trials comparing different types of endometrial destruction in this review; these are assessed in another Cochrane Review (<a href="./references#CD000329-bbs2-0018" title="Bofill RodriguezM , LethabyA , GrigoreM , BrownJ , HickeyM , FarquharC . Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database of Systematic Reviews2019, Issue 1. Art. No: CD001501. [DOI: 10.1002/14651858.CD001501.pub5]">Bofill Rodriguez 2019</a>). </p> <p>Details of included studies can be found in the Characteristics of included studies tables. </p> <section id="CD000329-sec-0051"> <h4 class="title">Results of the search</h4> <p>The previous version of this review included nine studies. The 2020 search identified 93 records after removal of duplicates. We excluded 92 records after reading the titles or abstracts. We obtained the full text of one article for assessment (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). This article had been included as an ongoing study in the previous version of the review. We included this study resulting in 10 included trials within this review . </p> </section> <section id="CD000329-sec-0052"> <h4 class="title">Included studies</h4> <p>Ten RCTs of endometrial resection/ablation versus hysterectomy with 1966 randomly assigned participants met the criteria for inclusion in the review, although not all participants contributed to the assessment of every outcome. We contacted six authors for further details: two replied (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>); four did not (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <section id="CD000329-sec-0053"> <h5 class="title">Study design</h5> <p>All included studies used a parallel‐group design. There were seven studies carried out at a single centre: three in Italy (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); three in the UK (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>); and one in India (<a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>). There were two multicentre studies performed in the UK, one in nine centres (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>), and one in 31 centres (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). There was one study completed at 25 centres in the USA and Canada (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </section> <section id="CD000329-sec-0054"> <h5 class="title">Participants</h5> <p>All participants were premenopausal, had symptomatic HMB (regular or irregular prolonged or excessive bleeding) and were eligible for (i.e. had shown no response to medical treatment) or were awaiting hysterectomy. Participants in seven included studies had received a diagnosis of menorrhagia (heavy regular bleeding) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), and participants in two studies had been diagnosed with dysfunctional uterine bleeding (defined as both regular and irregular ovulatory heavy bleeding and anovulatory abnormal bleeding not due to pathology) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> <p>Exclusion criteria included large fibroids (over 50% intramural extension (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>), or over 5 cm (<a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>)); large uterine size over 12 gestational weeks (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), or cavity over 11 cm (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>); pelvic inflammatory disease (PID) (<a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>); endometriosis (<a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>); and abnormal pathology and contraindication for laparoscopy (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). Four studies excluded participants with submucosal fibroids (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </section> <section id="CD000329-sec-0055"> <h5 class="title">Interventions</h5> <section id="CD000329-sec-0056"> <h6 class="title">Open hysterectomy</h6> <p> <ul id="CD000329-list-0017"> <li> <p>Two trials compared TCRE (ER) versus open hysterectomy (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>); <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a> also included a preoperative procedure (medroxyprogesterone acetate injection four to six weeks before surgery) to reduce the thickness of the endometrium for participants undergoing endometrial resection. </p> </li> </ul> </p> </section> <section id="CD000329-sec-0057"> <h6 class="title">Minimally invasive hysterectomy</h6> <p> <ul id="CD000329-list-0018"> <li> <p>One trial compared TCRE (ER) versus vaginal hysterectomy (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) </p> </li> <li> <p>One trial compared thermal balloon EA versus vaginal hysterectomy (<a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>). </p> </li> <li> <p>Two studies compared second‐generation EA versus laparoscopic supracervical hysterectomy. One versus thermal balloon (<a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>) and the second versus either thermal balloon or radiofrequency (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> </li> <li> <p>One study compared endometrial resection after preoperative gonadotrophin‐releasing hormone agonist (GnRHa) treatment versus laparoscopic supracervical hysterectomy (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0058"> <h6 class="title">Unspecified (or at surgeon's discretion) route of hysterectomy</h6> <p> <ul id="CD000329-list-0019"> <li> <p>One trial compared TCRE (ER) versus hysterectomy either abdominal (50%) or vaginal (50%) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </li> <li> <p>One trial compared endometrial destruction after preoperative gonadotrophin‐releasing hormone (GnRHa) treatment (50% endometrial resection and 50% laser ablation) versus hysterectomy (88% abdominal or 12% vaginal) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>One trial compared endometrial resection or thermal balloon ablation (according to surgeon's choice) versus total hysterectomy (vaginal, laparoscopic or abdominal approach, according to surgeon's choice) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0059"> <h5 class="title">Outcomes</h5> <p>Follow‐up after surgery for all included studies ranged from four months to four years.</p> <p>Seven studies assessed change in menstrual bleeding patterns (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>); five of these assessed whether menorrhagia‐like symptoms had resolved (amount and frequency of bleeding), one study (in which participants had a complaint of dysfunctional bleeding) measured separate components of bleeding excess (excessive amount and duration) and another study used PBAC questionnaires. </p> <p>Four studies assessed time to return to work in weeks (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>), and one assessed it in days (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> <p>Two studies in which participants had a diagnosis of dysfunctional bleeding assessed whether an improvement in overall symptoms had occurred (recorded in one trial as 'problem solved') (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> <p>Three studies measured costs of treatment (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> <p>Five studies assessed satisfaction with surgery (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>) (although this was reported at different follow‐ups); six trials reported postoperative complications (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>); and seven trials reported duration of surgery (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). Eight studies assessed hospital stay (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); and nine trials reported requirement for further surgery for treatment failure (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <p>Some outcomes measured time of surgery or recovery time and strictly speaking were time‐to‐event outcomes, such as duration of surgery, length of stay in hospital, and time to return to normal activities and work. However, these were analysed as continuous data, as all participants had initial and end values representing the time that had elapsed. Time‐to‐event analysis is mandatory when censoring is performed and only a subset of participants have an event, but the authors in this review considered comparison of means to be an acceptable analysis. </p> <p>Eight studies assessed quality of life after surgery (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), but used several different scales. This review assessed quality of life (continuous data) as measured by the Golombok Rust Inventory of Marital State (one year after surgery), the 36‐item Short Form (SF‐36), the EuroQol Visual Analogue Scale, HADS, Sabbatsberg Sexual Rating (SSR) Scale (all one or two years after surgery) and the 12‐item Short Form (SF‐12) (in one trial that was reported on a suitable way). The SF‐36 is a generic measure of subjective health in the form of a profile with eight multi‐item dimensions (including physical and emotional role limitation, physical and social functioning, mental health, energy, pain and general health perception) developed in the USA and shown to be an acceptable tool when used by women with HMB (<a href="./references#CD000329-bbs2-0025" title="CoulterA . Trends in gynaecological surgery (letter). Lancet1994;344:1367.">Coulter 1994</a>; <a href="./references#CD000329-bbs2-0056" title="WareJE , SnowKK , KosinskiM , GandekBG . SF-36 Health survey: manual and interpretation guide. In: The Health Institute. Boston (MA): New England Medical Centre, 1993.">Ware 1993</a>). The EuroQol health instrument is a generic single index measure of health‐related quality of life validated in several European countries, including the UK (<a href="./references#CD000329-bbs2-0020" title="BrazierJE , JonesNM , KindP . Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research1993;2(3):169-80.">Brazier 1993</a>; <a href="./references#CD000329-bbs2-0026" title="EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands)1990;16(3):199-208.">EuroQol Group 1990</a>). The Golombok Rust Inventory was modified by the investigators to obtain a brief measure of the overall quality of the marital relationship (<a href="./references#CD000329-bbs2-0050" title="RustJ , BennumI , CroweM , GolombokS . The construction and validation of the Golombok Rust Inventory of Marital State. Sexual and Marital Therapy1986;1:34-40.">Rust 1986</a>), and the SSR Scale was designed to provide a self‐assessment of sexual functioning by women engaging in intercourse (<a href="./references#CD000329-bbs2-0028" title="GarratAM , TorgersonDJ , WynessJ , HallMH , ReidDM . Measuring sexual functioning in premenopausal women. British Journal of Obstetrics and Gynaecology1995;102(4):311-6.">Garrat 1995</a>). HADS is a self‐assessment mood scale specifically designed to identify states of anxiety and depression and is regarded as a valid measure of the severity of these mood disorders (<a href="./references#CD000329-bbs2-0059" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67(6):361-70.">Zigmond 1983</a>). Several other scales were used to evaluate aspects of quality of life in some of the trials, including the SF‐12, General Health Questionnaire, the Psychosocial Adjustment to Illness Scale, a psychiatric mood scale, a modified social adjustment scale and an unvalidated questionnaire, but we did not enter these outcomes into the review because the data were not obtained in a suitable form for inclusion in a meta‐analysis (quantitative data provided in graphical form indicated significant skew; data could not be obtained from study authors). </p> <p>Three trials reported quality of life as dichotomous data (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). The first study as proportion with improvement in pain at two years' follow‐up (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>), and the second study as proportion with improvement in general health at one and four years after surgery (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). The third study reported the proportion of women with a score of 100 in the Menorrhagia Multi‐Attribute Scale (MMAS) (the best score possible in MMAS) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> <p>Five publications from three trials compared costs to the health service of the two techniques (Cameron 1996 and Aberdeen 1999 from the <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a> study; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; and Sculpher 1998 and Sculpher 1996 from the <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a> study). Two of these trials had two publications reporting total health resource costs of the procedures (including the need for retreatment) at different follow‐up times (Cameron 1996 and Aberdeen 1999 (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>); Sculpher 1993 and 1996 (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>)). One trial measured direct costs to the participant after one year (Cameron 1996 (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>)). </p> <p>Four publications from two trials calculated cost per participant based on resource use (Sculpher 1993 and Sculpher 1996 from <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>, and Cameron 1996 and Aberdeen 1999 from <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). The third trial calculated costs by summing the mean costs of variable resources and then adding a factor of 100% to allow for fixed costs (<a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). </p> </section> </section> <section id="CD000329-sec-0060"> <h4 class="title">Excluded studies</h4> <p>In the 2008 update of this review, two studies were retrieved for closer inspection and were excluded from the review (<a href="./references#CD000329-bbs2-0011" title="LinH . Comparison between microwave endometrial ablation and total hysterectomy. Chinese Medical Journal2006;119(14):1195-7. ">Lin 2006</a>; <a href="./references#CD000329-bbs2-0012" title="PaddisonK . Menorrhagia: endometrial ablation or hysterectomy. Nursing Standard2003;18(1):33-7. ">Paddison 2003</a>). One study had allocation according to date of admission and did not satisfy the criteria for true randomisation, and the other was a review of ablation versus hysterectomy. </p> <p>There were no further studies retrieved for closer inspection but subsequently excluded in the 2013, 2019 and 2020 updates of the review. </p> </section> </section> <section id="CD000329-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed all included studies separately for risk of bias (<a href="./references#CD000329-bbs2-0034" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We provide a summary of these assessments in <a href="#CD000329-fig-0002">Figure 2</a> and <a href="#CD000329-fig-0003">Figure 3</a>. </p> <section id="CD000329-sec-0062"> <h4 class="title">Allocation</h4> <p>Seven included studies provided sufficient detail on the adequacy of the randomisation method and were at low risk of selection bias (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). The other three studies did not describe how randomisation was undertaken and were, therefore, at unclear risk of bias. </p> <p>Seven studies provided sufficient details of allocation concealment and were at low risk of bias (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). Three studies provided insufficient details and were at unclear risk of bias (<a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </section> <section id="CD000329-sec-0063"> <h4 class="title">Blinding</h4> <p>Three of the more recent studies used single blinding for assessment of some outcomes (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). The other seven studies did not appear to have any blinding of participants, investigators or assessors. All studies were, therefore, at high risk of performance and detection bias. </p> </section> <section id="CD000329-sec-0064"> <h4 class="title">Incomplete outcome data</h4> <p>Two studies had withdrawals from the study or missing data were greater than 10% (or both), and there were no explanations enable judgement of whether this could have biased the results and were at unclear risk of attrition bias (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). One trial analysed primary outcomes by an intention‐to‐treat method (satisfaction rate, quality of life and bleeding outcomes), but analysed intraoperative and perioperative outcomes (adverse events, requirement for further surgery and hospital stay) according to surgery received (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). This trial also reported outcomes at three and four years' follow‐up, but as women who were assigned later during the trial had shorter follow‐up, these assessments are likely to be underpowered. The other seven studies had withdrawals of less than 10% at the time of calculation of outcomes at the first time point and were at low risk of attrition bias. However, in studies with longer follow‐up, additional loss to follow‐up increased with the duration of the trial. </p> </section> <section id="CD000329-sec-0065"> <h4 class="title">Selective reporting</h4> <p>Only one study provided sufficient information to indicate that it was free of selective outcome reporting was at low risk of reporting bias (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). Before publication of the study results, an earlier publication provided details of the study protocol and changes made throughout the study (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>: 2003 paper on Dickersin 2007). Three studies reported all the outcomes that were previously specified and were at low risk of reporting bias (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). The other studies provided no evidence of measures taken to prevent selective outcome reporting and were at unclear risk of bias. </p> </section> <section id="CD000329-sec-0066"> <h4 class="title">Other potential sources of bias</h4> <p>In all the studies, groups were balanced at baseline. Six studies described the prior experience of the operating surgeon (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). However, the other studies did not report this and were considered at unclear risk of other potential sources of bias as a less‐experienced surgeon for either treatment group could affect results such as duration of surgery, adverse outcomes and, in the case of EA/ER, effectiveness. </p> </section> </section> <section id="CD000329-sec-0067"> <h3 class="title" id="CD000329-sec-0067">Effects of interventions</h3> <p>See: <a href="./full#CD000329-tbl-0001"><b>Summary of findings 1</b> Endometrial resection or ablation compared to open hysterectomy for heavy menstrual bleeding</a>; <a href="./full#CD000329-tbl-0002"><b>Summary of findings 2</b> Endometrial resection or ablation versus minimally invasive hysterectomy for heavy menstrual bleeding</a>; <a href="./full#CD000329-tbl-0003"><b>Summary of findings 3</b> Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy for heavy menstrual bleeding</a> </p> <p>We included 10 trials that allowed the following comparisons.</p> <p> <ul id="CD000329-list-0020"> <li> <p>Comparison 1. Endometrial resection/ablation versus open hysterectomy.</p> </li> <li> <p>Comparison 2. Endometrial resection/ablation versus minimally invasive hysterectomy.</p> </li> <li> <p>Comparison 3. Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy. </p> </li> </ul> </p> <section id="CD000329-sec-0068"> <h4 class="title">1 Endometrial resection/ablation versus open hysterectomy</h4> <p>Two trials (247 women) compared TCRE (ER) versus abdominal hysterectomy (<a href="./full#CD000329-tbl-0001">summary of findings Table 1</a>) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). </p> <section id="CD000329-sec-0069"> <h5 class="title">Primary outcomes</h5> <section id="CD000329-sec-0070"> <h6 class="title">Effectiveness</h6> <section id="CD000329-sec-0071"> <p><b>1.1 Woman's perception (proportion with improvement in bleeding symptoms)</b></p> <p>Both trials assessed whether bleeding symptoms were perceived as improved (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). Women randomly assigned to EA/ER were less likely to show improvement in bleeding symptoms when compared with those randomly assigned to open hysterectomy at one year (RR 0.90, 95% CI 0.84 to 0.95; I² = 0%; 247 women; moderate‐certainty evidence) (<a href="./references#CD000329-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD000329-sec-0072"> <p><b>1.2 Quality‐of‐life scores (continuous data)</b></p> <p>One trial measured quality of life (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). There appeared to be a benefit in pain at two years for the hysterectomy group (MD –9.90, 95% CI –17.63 to –2.17; 155 women; <a href="./references#CD000329-fig-0005" title="">Analysis 1.2</a>). For all other outcomes, there was no clear evidence of benefit or harm between TCRE and open hysterectomy at two years' follow‐up; perception of general health at two years (MD –5.30, 95% CI –11.90 to 1.30; 155 women; moderate‐certainty evidence); role limitation, physical at two years (MD 0.70, 95% CI –9.82 to 11.22); role limitation, emotional at two years (MD –6.20, 95% CI –15.87 to 3.47); social functioning at two years (MD –6.00, 95% CI –12.11 to 0.11); mental health at two years (MD –2.30, 95% CI –7.49 to 2.89); energy at two years (MD –1.50, 95% CI –8.18 to 5.18) and physical functioning at two years (MD –2.50, 95% CI –7.56 to 2.56). </p> <p>One trial assessed quality of life with the EuroQoL and reported no clear evidence of a difference at either one year after surgery (MD –7.00, 95% CI –17.29 to 3.29) or at two years after surgery (MD –1.50, 95% CI –6.29 to 3.29) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). </p> </section> <section id="CD000329-sec-0073"> <p><b>1.3 Quality of life (proportion with improvement)</b></p> <p>According to one trial, there was no clear evidence of a difference in the proportion with improvement in quality of life in terms of pain at two years' follow‐up (RR (non‐event) 1.60, 95% CI 0.55 to 4.63; <a href="./references#CD000329-fig-0006" title="">Analysis 1.3</a>) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). </p> </section> <section id="CD000329-sec-0074"> <p><b>1.4 Requirement for further surgery for treatment failure</b></p> <p>Risk of repeat surgery for treatment failure is zero when women have a total hysterectomy, this is a structural zero (will always be zero, and it is not random), as the bleeding was from the removed uterus, thus the calculation of RR may result in biased estimates (<a href="./references#CD000329-bbs2-0053" title="SweetingM , SuttonA , LambertP . What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine2004;23(9):1361-75. [DOI: 10.1002/sim.1761]">Sweeting 2004</a>; <a href="./references#CD000329-bbs2-0054" title="TangW , HeH , WangWJ , ChenDG . Untangle the structural and random zeros in statistical modelings. Journal of applied statistics2018;45(9):1714-33. [DOI: 10.1080/02664763.2017.1391180]">Tang 2018</a>). The risk of having a further surgery for treatment failure on the EA/ER group was 12.9% at one year (compared to 0 on the total hysterectomy group; I² = 0%; 2 studies, 247 women; moderate‐certainty evidence) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>), and 33% at two years' follow‐up (1 trial, 196 women) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>) (<a href="./references#CD000329-fig-0007" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD000329-sec-0075"> <h6 class="title">Acceptability</h6> <section id="CD000329-sec-0076"> <p><b>1.5 Proportion satisfied with treatment</b></p> <p>One trial (194 women) reported satisfaction (very or moderately satisfied) rates (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). Compared to the open hysterectomy group, satisfaction rate was lower among women who had EA/ER at one year after surgery (RR 0.91, 95% CI 0.82 to 1.00) and two years after surgery (RR 0.82, 95% CI 0.73 to 0.93; moderate‐certainty evidence; <a href="./references#CD000329-fig-0008" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD000329-sec-0077"> <h6 class="title">Safety (adverse outcomes)</h6> <section id="CD000329-sec-0078"> <p><b>1.6 Any serious adverse events</b></p> <p>Both studies reported adverse events (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). There was no clear evidence of a difference for any serious adverse events (RR 1.29, 95% CI 0.32 to 5.20; I² = 59%; 2 studies, 247 women; low‐certainty evidence; <a href="./references#CD000329-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD000329-sec-0079"> <p><b>1.7 Adverse events: short term (intraoperative and immediately postoperative)</b></p> <p>There was clear evidence of a difference between procedures in terms of the following short‐term adverse effects favouring endometrial resection/ablation (<a href="./references#CD000329-fig-0010" title="">Analysis 1.7</a>): </p> <p> <ul id="CD000329-list-0021"> <li> <p>1.7.1 Sepsis (RR 0.07, 95% CI 0.02 to 0.25; I² = 0%; 2 studies; 247 women) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>); </p> </li> <li> <p>1.7.2 Pyrexia (RR 0.07, 95% CI 0.02 to 0.28; 1 study, 196 women) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>); </p> </li> <li> <p>1.7.3 Vault haematoma (RR 0.16, 95% CI 0.03 to 0.86; I² = 0%; 2 studies, 247 women) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>); </p> </li> </ul> </p> <p>There was no clear evidence of a difference in blood transfusion between groups in one trial. </p> <p> <ul id="CD000329-list-0022"> <li> <p>1.7.4 Blood transfusion (RR 0.33, 95% CI 0.07 to 1.58; 196 women) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0080"> <p><b>1.8 Adverse events: long term (after hospital discharge)</b></p> <p>One trial reported long‐term adverse events, and there was no clear evidence of a difference between procedures (<a href="./references#CD000329-fig-0011" title="">Analysis 1.8</a>). </p> <p> <ul id="CD000329-list-0023"> <li> <p>1.8.1 Haematoma (RR 0.20, 95% CI 0.01 to 4.03; 196 women; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>); </p> </li> <li> <p>1.8.2 Haemorrhage (RR 2.94, 95% CI 0.12 to 71.30; 196 women; <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). </p> </li> </ul> </p> </section> </section> </section> <section id="CD000329-sec-0081"> <h5 class="title">Secondary outcomes</h5> <section id="CD000329-sec-0082"> <h6 class="title">1.9 Duration of surgery</h6> <p>Both trials reported the duration of surgery (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>), and, even though there was very high heterogeneity (we could not pool the data), the direction of effect was the same and it was consistently longer on the open hysterectomy groups compared to the Endometrial resection/ablation group (<a href="./references#CD000329-fig-0012" title="">Analysis 1.9</a>). Reasons for heterogeneity may have included skills of the surgeons, type of anaesthesia, characteristics of the women and the method used to record duration of the surgery. </p> </section> <section id="CD000329-sec-0083"> <h6 class="title">1.10 Duration of hospital stay</h6> <p>Both trials evaluated duration of hospital stay (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). We noted a high heterogeneity in the results. Despite this, both studies reported shorter hospital stays for EA/ER compared to open hysterectomy (<a href="./references#CD000329-fig-0013" title="">Analysis 1.10</a>). Reasons for heterogeneity may have included hospital protocols for discharge, geographic conditions and time when the trial took place. </p> </section> <section id="CD000329-sec-0084"> <h6 class="title">1.11 Time to return to normal activity</h6> <p>One trial reported time to return to normal activity (in days) (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>). There was clear evidence of a difference between groups favouring EA/ERor resection in time to return to normal activities compared to the open hysterectomy group (MD –21.00, 95% CI –24.78 to –17.22; <a href="./references#CD000329-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD000329-sec-0085"> <h6 class="title">1.12 Time to return to work</h6> <p>Both trials reported time to return work (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). Time to return to work (in weeks) showed a high heterogeneity, but the direction of the effect presented a clear difference favouring the Endometrial resection/ablation compared to open hysterectomy (MD –7.72 days, 95% CI –8.05 to –7.38; I² = 81%; 245 women; <a href="./references#CD000329-fig-0015" title="">Analysis 1.12</a>). Reasons for heterogeneity may have included different protocols, types of job and geographical reasons to stay away from work. </p> </section> <section id="CD000329-sec-0086"> <h6 class="title">1.13 Total health service cost per woman</h6> <p>Both trials assessed the health service costs (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>; <a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>). There was clear evidence of a difference between groups favouring Endometrial resection/ablation for the management of HMB at short‐term follow‐up and, in one trial (<a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a>), the difference was still clear up to two years' follow‐up (<a href="./references#CD000329-fig-0016" title="">Analysis 1.13</a>). </p> </section> </section> </section> <section id="CD000329-sec-0087"> <h4 class="title">2 Endometrial resection/ablation versus minimally invasive hysterectomy</h4> <p>Five trials (990 women) assessed endometrial resection/ablation versus minimally invasive hysterectomy (<a href="./full#CD000329-tbl-0002">summary of findings Table 2</a>). Two compared second‐generation EA versus laparoscopic supracervical hysterectomy; one versus thermal balloon (<a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>), and one versus either thermal balloon or radiofrequency (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). One compared TCRE (ER) versus vaginal hysterectomy (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>), one compared thermal balloon EA versus vaginal hysterectomy (<a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>) and one compared endometrial resection (after preoperative GnRHa) treatment versus laparoscopic supracervical hysterectomy (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <section id="CD000329-sec-0088"> <h5 class="title">Primary outcomes</h5> <section id="CD000329-sec-0089"> <h6 class="title">Effectiveness</h6> <section id="CD000329-sec-0090"> <p><b>2.1 Woman's perception (proportion with improvement in bleeding symptoms)</b></p> <p>One trial assessed the woman's perception of improvement in bleeding symptoms, reporting no clear evidence of a difference (RR 0.97, 95% CI 0.90 to 1.04; 79 women; low‐certainty evidence; <a href="./references#CD000329-fig-0017" title="">Analysis 2.1</a>) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>). </p> </section> <section id="CD000329-sec-0091"> <p><b><i>2.2</i> Pictorial Blood Loss Assessment Chart <i>score</i> </b></p> <p>One trial assessed menstrual blood loss using the PBAC score (<a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). Compared with pretreatment scores, the PBAC score was clearly reduced in both groups at one and two years postoperatively; however, this finding overall favoured women randomly assigned to minimally invasive hysterectomy at one year (MD 24.40, 95% CI 16.01 to 32.79; 68 women; low‐certainty evidence), and even more so at two years (MD 44.00, 95% CI 36.09 to 51.91; 68 women) (<a href="./references#CD000329-fig-0018" title="">Analysis 2.2</a>). </p> </section> <section id="CD000329-sec-0092"> <p><b>2.3 Quality‐of‐life scores (continuous data)</b></p> <p>Studies measured quality of life using several validated scales. It was not possible to combine scales, as the domains differed, measuring different aspects of quality of life. </p> <p>There was a high heterogeneity with an I² statistic greater than 90%, which does not allow us to make any conclusion. There was no clear evidence of benefit or harm. </p> <p>Some studies reported benefits for minimally invasive hysterectomy compared to EA/ER. One study (181 women) reported benefit favouring the minimally invasive group using the SF‐36 at one year' follow‐up for social functioning (MD –21.20, 95% CI –24.73 to –17.67), energy (MD –11.30, 95% CI –14.82 to –7.78), general health perception (MD –9.80, 95% CI –13.86 to –5.74) and physical functioning (MD –1.20, 95% CI –5.34 to 2.94) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). Two studies (145 women) reported benefit favouring the minimally invasive surgery compared to EA/ER, using SF‐36, at two years for social functioning (MD –12.02, 95% CI –16.26 to –7.77; I² = 0%), general health perception (MD –10.71, 95% CI –15.11 to –6.30; I² = 0%), pain (MD –12.68, 95% CI –17.09 to –8.27; I² = 35%) and physical functioning (MD –15.59, 95% CI –20.47 to –10.72; I² = 89%) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). </p> <p>In contrast, the pooled results of two studies (145 women) suggested benefits for EA/ER compared to minimally invasive hysterectomy, using the SF‐36, at two years on role limitation (emotional) (MD 15.41, 95% CI 9.97 to 20.85; I² = 89%). (<a href="./references#CD000329-fig-0019" title="">Analysis 2.3</a>) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). </p> <p>There was no clear evidence of a difference, between EA/ER and minimally invasive hysterectomy, on the remaining parameters at one and two years. </p> <p>The remaining parameters at one year using the SF‐36 were role limitation, physical (MD –0.80, 95% CI –4.99 to 3.39; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), role limitation, emotional (MD –3.90, 95% CI –8.21 to 0.41; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), mental health (MD –2.70, 95% CI –6.84 to 1.44; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), pain (MD –1.50, 95% CI –6.05 to 3.05; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); and using SF‐12 were physical score (MD –1.10, 95% CI –2.78 to 0.58; 1 study, 435 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>), and mental score (MD –1.90, 95% CI –4.00 to 0.20; 1 study, 435 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> <p>The remaining parameters at two years' follow up were role limitation, physical (MD –4.12, 95% CI –9.58 to 1.35; I² = 0%; 2 studies, 145 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>), SSR Scale (MD –3.70, 95% CI –11.17 to 3.77; 1 study, 77 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>), total HADS scores (MD –1.50, 95% CI –4.32 to 1.32; 1 study, 77 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>), anxiety HADS scores (MD –1.60, 95% CI –3.28 to 0.08; 1 study, 77 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>), and depression HADS scores (MD –0.60, 95% CI –2.28 to 1.08; 1 study, 77 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>). </p> <p>Energy and mental health at two years follow up using the SF 36 were reported by two trials (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>), the results were inconclusive with heterogeneity over 90%. The mean difference between EA/ER and minimally invasive hysterectomy for energy was ‐11.30(95% CI ‐20.21 to 2.39) in <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a> and 11.1 (95% CI 5.33 to 16.87 in <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; and for mental health was ‐4.70(95% CI ‐13.33 to 3.93 in <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) and 13.50 (95% CI 8.35 to 18.65 in <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>. </p> </section> <section id="CD000329-sec-0093"> <p><b>2.4 Quality of life (proportion with improvement)</b></p> <p>One trial reported quality of life measured using the MMAS (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>), it was reported as the proportion of women with MMAS = 100 (the best score possible) at 15 months after randomisation (approximately 12 months after surgery). Women on the minimally invasive hysterectomy group were probably more likely to have a better quality of life measured with MMAS compared to the EA/ER group (RR 0.82, 95% CI 0.70 to 0.95; 616 women; moderate‐certainty evidence) (<a href="./references#CD000329-fig-0020" title="">Analysis 2.4</a>). </p> </section> <section id="CD000329-sec-0094"> <p><b>2.5 Quality of life at 14 years' follow‐up</b></p> <p>One trial, using the SF‐12, reported physical and mental quality of life at 14 years' follow‐up (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), suggesting a higher quality of life in the minimally invasive hysterectomy group compared to the ablation group. There was clear evidence of a difference favouring minimally invasive surgery compared to EA/ER on the physical component score (ranged from 57.50 to 51.40 for minimally invasive hysterectomy and from 55.04 to 45.40 for ablation) and on the mental component (ranged from 56.80 to 50.40 for minimally invasive hysterectomy and from 51.90 to 36.10 for ablation). A higher score denotes a better quality of life. We could not enter these data in the meta‐analysis (<a href="./references#CD000329-fig-0021" title="">Analysis 2.5</a>). </p> </section> <section id="CD000329-sec-0095"> <p><b><i>2.6 Requirement for further surgery for treatment failure</i> </b></p> <p>Studies reported risk of repeat surgery for failure of the initial surgical treatment at different follow‐up times. Four trials reported the requirement for further surgery at one year's follow‐up (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); three reported at two years' follow‐up (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); and one reported at 14 years' follow‐up (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <p>The risk of having a further surgery for treatment failure was more likely for EA/ER than for minimally invasive hysterectomy at all follow‐up periods (<a href="./references#CD000329-fig-0022" title="">Analysis 2.6</a>). We reported for this comparison the relative risk as women having minimally invasive hysterectomy may have a subtotal hysterectomy that could (exceptionally) lead to a treatment failure (this is not a structural zero as explained in 1.4 above). </p> <p> <ul id="CD000329-list-0024"> <li> <p>2.6.1 At one year' follow‐up (RR 7.70, 95% CI 2.54 to 23.32; I² = 0%; 4 studies, 922 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). There were only two surgeries in the hysterectomy group: one that was allocated to laparoscopic hysterectomy but received EA/ER and the second was a subtotal laparoscopic hysterectomy that required the cervix to be surgically removed for persistent bleeding. </p> </li> <li> <p>2.6.2 At two years' follow‐up (RR 16.75, 95% CI 2.24 to 125.34; I² = 0%; 3 studies, 334 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.6.3 At 14 years' follow‐up (RR 19.60, 95% CI 1.15 to 333.63; 1 study, 153 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0096"> <h6 class="title">Acceptability</h6> <section id="CD000329-sec-0097"> <p><b><i>2.7 Proportion satisfied with treatment</i> </b></p> <p>One trial reported satisfaction rate (very or moderately satisfied) at one (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>) and two years' follow‐up (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>). There was clear evidence of a difference in satisfaction rate favouring minimally invasive hysterectomy compared to EA/ER at one year (RR 0.90, 95% CI 0.85 to 0.94; 558 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). At two years, there was no clear evidence of a difference between groups (RR 0.92, 95% CI 0.79 to 1.06; 77 women) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) (<a href="./references#CD000329-fig-0023" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD000329-sec-0098"> <h6 class="title">Safety (adverse outcomes)</h6> <section id="CD000329-sec-0099"> <p><b>2.8 Any serious adverse events</b></p> <p>All studies in this comparison reported adverse events. Four trials reported the number of women with any serious adverse events (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0009" title="SestiF , RuggeriV , PietropolliA , PiancatelliR , PiccioneE . Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. Journal of Obstetrics and Gynaecology Research2011;37(11):1650-7. ">Sesti 2011</a>). One study reported only a list of adverse events, even though some serious adverse events were reported on the list, we did not include the data on the analysis due to the high risk of double counting (e.g. readmission, cardiorespiratory event and thromboembolic event, all in the same list, as it is unclear if that could be one or three women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>) (<a href="./references#CD000329-fig-0024" title="">Analysis 2.8</a>). </p> <p>There was no clear evidence of a difference on the incidence of serious adverse events between groups (RR 0.75, 95% CI 0.35 to 1.59; I² = 0%; 4 studies, 809 women). </p> </section> <section id="CD000329-sec-0100"> <p><b>2.9 Adverse events: short term (intraoperative and immediately postoperative)</b></p> <p>Three trials reported short‐term adverse effects (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <p>There was no clear evidence of a difference between EA/ER and minimally invasive hysterectomy in any of the adverse effects reported (<a href="./references#CD000329-fig-0025" title="">Analysis 2.9</a>). </p> <p> <ul id="CD000329-list-0025"> <li> <p>2.9.1 Sepsis (RR 1.01, 95% CI 0.29 to 3.44; 1 study, 616 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> </li> <li> <p>2.9.2 Blood transfusion (RR 0.68, 95% CI 0.11 to 4.08; I² = 30%; 3 studies, 837 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0006" title="JainP , RajaramS , GuptaB , GoelN , SrivastavaH . Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. International Journal of Gynaecology and Obstetrics2016;135(2):140-4. [doi.org/10.1016/j.ijgo.2016.04.020]">Jain 2016</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.3 Pyrexia (RR 0.73, 95% CI 0.24 to 2.27; 2 studies, 797 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.4 Vault haematoma (RR 0.21, 95% CI 0.01 to 4.25; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.5 Fluid overload (RR 11.37, 95% CI 0.64 to 202.59; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.6 Haemorrhage (RR 0.86, 95% CI 0.27 to 2.74; 2 studies, 797 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.7 Perforation (RR 3.02, 95% CI 0.32 to 28.87; 1 study, 616 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> </li> <li> <p>2.9.8 Laparotomy (RR 0.52, 95% CI 0.05 to 5.60; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> <li> <p>2.9.9 Cystotomy (bladder injury) (RR 0.34, 95% CI 0.01 to 8.20; 1 study, 616 women) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>). </p> </li> <li> <p>2.9.10 Cervical laceration (RR 3.10, 95% CI 0.13 to 75.10; 1 study, 181 women) (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0101"> <p><b>Adverse events: long term (after hospital discharge)</b></p> <p>There were no reports about adverse events after hospital discharge for this comparison.</p> </section> </section> </section> <section id="CD000329-sec-0102"> <h5 class="title">Secondary outcomes</h5> <section id="CD000329-sec-0103"> <h6 class="title">2.10 Duration of surgery</h6> <p>All trials reported the duration of surgery. We were unable to pool the data due to a high heterogeneity (98%), but the direction of the effect was clear, and in general EA/ER reported shorter surgical times than minimally invasive hysterectomy, with an MD ranging from 30 minutes' to two hours' between trials. There was also a difference in operation time for each individual procedure, ranging the EA/ER from 13 to 44 minutes and the minimally invasive hysterectomy from 70 to 150 minutes. Reasons for heterogeneity may have included skills of the surgeons, type of anaesthesia, characteristics of the women and the method used to record duration of the surgery (<a href="./references#CD000329-fig-0026" title="">Analysis 2.10</a>). </p> </section> <section id="CD000329-sec-0104"> <h6 class="title">2.11 Duration of hospital stay</h6> <p>Three trials evaluated duration of hospital stay (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). We did not pool data in this analysis as we noted a high degree of heterogeneity (100%) (<a href="./references#CD000329-fig-0027" title="">Analysis 2.11</a>). There was a wide range of differences in hospital stay for each individual procedure, ranging from 3 to 30 hours for EA/ER and from under 24 hours to five days for minimally invasive hysterectomy. Reasons for the heterogeneity may have included hospital protocols for discharge, geographic conditions and time when the trial took place (there was a clear difference on the time spent in hospital for minimally invasive hysterectomy in the older trial compared to more recent ones). </p> <p>Despite the high heterogeneity, all studies reported shorter hospital stays for EA/ER compared to hysterectomy. </p> </section> <section id="CD000329-sec-0105"> <h6 class="title">2.12 Time to return to normal activity</h6> <p>Two trials reported time to return to normal activity (in days) (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>); one trial reported it as time to return to unpaid work (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>) (<a href="./references#CD000329-fig-0028" title="">Analysis 2.12</a>). We do not include a pooled estimate in this analysis as we noted a high degree of heterogeneity (100%). The direction of the effect was consistent to having shorter periods of time to return to either normal life or to unpaid work with EA resection compared to minimally invasive hysterectomy. Causes of heterogeneity may have included hospital protocols, doctors' instructions and insurance allowance of time off work. The time to return to normal activities on the EA/ER group reported a range that was fairly similar between the trials (six days <a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; eight days <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; eight days <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), but the results for the minimally invasive hysterectomy group reported a wide range (21 days <a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; 13 days <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; 10 days <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> </section> <section id="CD000329-sec-0106"> <h6 class="title">2.13 Time to return to work</h6> <p>Three trials reported time to return to work (in weeks) (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>) (<a href="./references#CD000329-fig-0029" title="">Analysis 2.13</a>). We were unable to pool the data due to a 100% heterogeneity. One trial reported that women returned to work at 3.5 days after either procedure showing no clear evidence of a difference between groups (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). This is markedly different to results in the other two studies reporting this outcome, reporting one (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>) and two weeks (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) for EA/ER; and four (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) or five (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>) weeks for minimally invasive hysterectomy. </p> <p>Both data for time to return to unpaid work and time to return to work in <a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a> were reported in median and interquartile range (IQR), we calculated the mean and SD according to <a href="./references#CD000329-bbs2-0035" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471-2288-5-13]">Hozo 2005</a>. </p> <p>For both outcomes due to high heterogeneity, we tested the effect estimate by removing each study in turn; heterogeneity remained high: one was 83%, and the others were 98% and above. </p> </section> <section id="CD000329-sec-0107"> <h6 class="title">2.14 Cost</h6> <p>None of the studies reported costs.</p> </section> </section> </section> <section id="CD000329-sec-0108"> <h4 class="title">3 Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy </h4> <p>Three trials assessed EA/ER versus unspecified (or at surgeon's discretion) route of hysterectomy (<a href="./full#CD000329-tbl-0003">summary of findings Table 3</a>): one compared TCRE versus hysterectomy (50% abdominal and 50% vaginal) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>); one compared endometrial destruction after preoperative GnRH treatment (50% endometrial resection and 50% laser ablation) versus hysterectomy (88% abdominal and 12% vaginal) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>); and one compared endometrial resection or thermal balloon ablation (at surgeon's discretion) versus total hysterectomy (vaginal, laparoscopic or abdominal approach, at surgeon's discretion) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> <section id="CD000329-sec-0109"> <h5 class="title">Primary outcomes</h5> <section id="CD000329-sec-0110"> <h6 class="title">Effectiveness</h6> <section id="CD000329-sec-0111"> <p><b>3.1 Woman's perception (proportion with improvement in bleeding symptoms)</b></p> <p>Two trials assessed whether bleeding symptoms were perceived as improved at one, two or four years' follow‐up (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). Women on the unspecified (or at surgeon's discretion) route of hysterectomy were more likely to perceive an improvement in bleeding symptoms up to four years' follow‐up (<a href="./references#CD000329-fig-0030" title="">Analysis 3.1</a>). </p> <p> <ul id="CD000329-list-0026"> <li> <p>3.1.1 At one year' follow‐up (RR 0.89, 95% CI 0.83 to 0.95; I² = 72%; 2 studies, 403 women; low‐certainty evidence) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.1.2 At two years' follow‐up (RR 0.90, 95% CI 0.82 to 0.99; 1 study, 213 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.1.3 At four years' follow‐up (RR 0.93, 95% CI 0.88 to 0.99; I² = 79%; 2 studies, 237 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0112"> <p><b>Pictorial Blood Loss Assessment Chart score</b></p> <p>None of the trials reported of PBAC score.</p> </section> <section id="CD000329-sec-0113"> <p><b>3.2 Quality‐of‐life scores (continuous data)</b></p> <p>Trials measured quality of life using several validated scales. It was not possible to combine scales, as the domains differed, measuring different aspects of quality of life (<a href="./references#CD000329-fig-0031" title="">Analysis 3.2</a>). </p> <p>There was no evidence of clear difference between groups in all quality‐of‐life categories but one: </p> <p> <ul id="CD000329-list-0027"> <li> <p>3.2.7 Energy at two years' follow‐up measured with SF‐36 (MD –15.60, 95% CI –22.47 to –8.73; 1 study, 213 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> </ul> </p> <p>All the remaining parameters reported no clear evidence of a difference between the EA/ER group versus the unspecified (or at surgeon's discretion) route of hysterectomy. </p> <p> <ul id="CD000329-list-0028"> <li> <p>3.2.1 Mental health at one year using the SF‐36 (MD 1.60, 95% CI –5.17 to 8.37; 1 study, 204 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.2 Energy at one year using the SF‐36 (MD –2.30, 95% CI –20.90 to 16.30; 1 study, 204 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.3 Pain at one year using the SF‐36 (MD –2.80, 95% CI –9.53 to 3.93; 1 study, 210 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.4 General health perception at one year using the SF‐36 (MD –0.70, 95% CI –7.24 to 5.84; 1 study, 204 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.5 Pain at two years using the SF‐36 (MD –2.40, 95% CI –8.86 to 4.06; 1 study, 213 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.6 General health perception at two years using the SF‐36 (MD –1.90, 95% CI –8.67 to 4.87; 1 study, 209 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.8 Golombok Rust Inventory of Marital State scores at one year after surgery (MD 0.00, 95% CI –1.75 to 1.75; 1 study, 182 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.2.9 EuroQol scores within one year after surgery (MD –2.00, 95% CI –7.90 to 3.90; 1 study, 210 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.10 EuroQol scores at two years after surgery (MD –2.60, 95% CI –8.20 to 3.00; 1 study, 213 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.2.11 Anxiety HADS scores at one year after surgery (MD –0.20, 95% CI –1.39 to 0.99; 1 study, 182 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.2.12 Depression HADS scores at one year after surgery (MD 0.00, 95% CI –0.09 to 0.09; 1 study, 182 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0114"> <p><b>3.3 Quality of life (proportion with improvement)</b></p> <p>One trial reported the proportion of participants with improvement in general health at one and four years (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). A greater proportion of women who had undergone an unspecified (or at surgeon's discretion) route of hysterectomy reported an improvement in their general health one year after surgery when compared with women who received EA/ER (RR 0.85, 95% CI 0.77 to 0.95; 185 women); but at four years, this difference between groups had narrowed and there was no evidence of a clear difference (RR 0.89, 95% CI 0.80 to 1.00; 146 women) (<a href="./references#CD000329-fig-0032" title="">Analysis 3.3</a>). </p> <p>None of the studies reported quality of life using MMAS.</p> </section> <section id="CD000329-sec-0115"> <p><b>3.4 Requirement for further surgery for treatment failure</b></p> <p>Studies reported risk of repeat surgery for failure of the initial surgical treatment at different follow‐up times. Two trials reported the requirement for further surgery at one year' follow‐up (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>); two reported at two years' follow‐up (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>); one reported at three years' follow‐up (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>); and one at four years' follow‐up (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> <p>The risk of having a further surgery for treatment failure was more likely for EA/ER than for the unspecified (or at surgeon's discretion) route of hysterectomy at all follow‐up periods (<a href="./references#CD000329-fig-0033" title="">Analysis 3.4</a>). </p> <p> <ul id="CD000329-list-0029"> <li> <p>3.4.1 Both trials reporting further surgery for treatment failure at one year included only total vaginal and abdominal hysterectomies. Risk of repeat surgery for treatment failure is zero when women have a total hysterectomy, this is a structural zero (will always be zero, and it is not random), as the bleeding was from the removed uterus, thus the calculation of RR may result in biased estimates (<a href="./references#CD000329-bbs2-0053" title="SweetingM , SuttonA , LambertP . What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine2004;23(9):1361-75. [DOI: 10.1002/sim.1761]">Sweeting 2004</a>; <a href="./references#CD000329-bbs2-0054" title="TangW , HeH , WangWJ , ChenDG . Untangle the structural and random zeros in statistical modelings. Journal of applied statistics2018;45(9):1714-33. [DOI: 10.1080/02664763.2017.1391180]">Tang 2018</a>). The risk of having a further surgery for treatment failure on the EA/ER group was 5.4% % at one year (I² = 0%; 2 studies, 374 women; moderate‐certainty evidence) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.4.2 At two years' follow‐up (RR 35.70, 95% CI 5.30 to 240.55; I² = 0%; 2 studies, 400 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </li> <li> <p>3.4.3 At three years' follow‐up (RR 22.90, 95% CI 1.42 to 370.26; 1 study, 172 women) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </li> <li> <p>3.4.4 At four years' follow‐up (RR 73.63, 95% CI 4.59 to 1181.42; 1 study, 197 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> <p>One study reported three requirements for further surgery in the hysterectomy group (two oophorectomies and one cystoscopy for persistent urinary symptoms after the surgery), but no further surgery for HMB. </p> </section> </section> <section id="CD000329-sec-0116"> <h6 class="title">Acceptability</h6> <section id="CD000329-sec-0117"> <p><b>3.5 Proportion satisfied with treatment</b></p> <p>Three trials reported satisfaction (very or moderately satisfied) rates (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). There was no clear evidence of a difference on the satisfaction rate between groups at any follow‐up time (<a href="./references#CD000329-fig-0034" title="">Analysis 3.5</a>). </p> <p> <ul id="CD000329-list-0030"> <li> <p>3.5.1 Within the first year (RR 0.96, 95% CI 0.88 to 1.04; I² = 0%; 3 studies, 545 women; moderate‐certainty evidence) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.5.2 At two years' follow‐up (RR 0.89, 95% CI 0.77 to 1.03; I² = 0%; 2 studies, 337 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </li> <li> <p>3.5.3 At four years' follow‐up (RR 0.89, 95% CI 0.77 to 1.03; I² = 0%; 2 studies, 246 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> </section> </section> <section id="CD000329-sec-0118"> <h6 class="title">Safety (adverse events)</h6> <section id="CD000329-sec-0119"> <p><b>3.6 Any serious adverse events</b></p> <p>All studies reported adverse events. Two reported the number of women with any serious adverse events (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). One study reported only a list of adverse events, even though some serious adverse events were reported on the lists, we did not include the data on the analysis due to the high risk of double counting (e.g. readmission, cardiorespiratory event and thromboembolic event), as it is unclear if that could be one or three women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> <p>There was clear evidence of a difference on serious adverse events favouring EA/ER compared with unspecified (or at surgeon's discretion) hysterectomy (RR 0.21, 95% CI 0.06 to 0.80; I² = 0%; 2 studies, 374 women; moderate‐certainty evidence; <a href="./references#CD000329-fig-0035" title="">Analysis 3.6</a>) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </section> <section id="CD000329-sec-0120"> <p><b>3.7 Adverse events: short term (intraoperative and immediately postoperative)</b></p> <p>Three trials reported short‐term adverse effects (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> <p>There was clear evidence of a difference between EA/ER and unspecified (or at surgeon's discretion) route of hysterectomy favouring EA/ER in the following adverse effects (<a href="./references#CD000329-fig-0036" title="">Analysis 3.7</a>). </p> <p> <ul id="CD000329-list-0031"> <li> <p>3.7.1 Sepsis (RR 0.27, 95% CI 0.17 to 0.44; I² = 61%; 2 studies, 374 women) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.2 Blood transfusion (RR 0.13, 95% CI 0.02 to 0.70; I² = 0%; 2 studies, 374 women) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.3 Pyrexia (RR 0.21, 95% CI 0.08 to 0.61; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.7.4 Vault haematoma (RR 0.08, 95% CI 0.02 to 0.42; I² = 0%; 2 studies, 430 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.5 Wound haematoma (RR 0.03, 95% CI 0 to 0.53; 1 study, 202 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> <p>However, there was clear evidence of a difference between EA/ER and unspecified (or at surgeon's discretion) route of hysterectomy favouring unspecified (or at surgeon's discretion) hysterectomy in the following adverse effects (<a href="./references#CD000329-fig-0036" title="">Analysis 3.7</a>). </p> <p> <ul id="CD000329-list-0032"> <li> <p>3.7.6 Fluid overload (RR 8.59, 95% CI 1.59 to 46.36; I² = 0%; 2 studies, 430 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> </ul> </p> <p>There was no clear evidence of a difference between groups for the following adverse effects (<a href="./references#CD000329-fig-0036" title="">Analysis 3.7</a>). </p> <p> <ul id="CD000329-list-0033"> <li> <p>3.7.7 Haemorrhage (RR 0.61, 95% CI 0.24 to 1.57; I² = 68%; 2 studies, 374 women) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.8 Anaesthetic complications (RR 0.18, 95% CI 0.01 to 3.80; 1 study, 202 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.9 Perforation (RR 5.05, 95% CI 0.61 to 42.16; I² = 0%; 2 studies, 430 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.10 Gastrointestinal obstruction (RR 0.46, 95% CI 0.04 to 5.01; 1 study, 202 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.11 Laparotomy (RR 0.31, 95% CI 0.03 to 2.91; 1 study, 202 women) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). </p> </li> <li> <p>3.7.12 Cystotomy (bladder injury) (RR 0.21, 95% CI 0.01 to 4.42; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.7.13 Cervical laceration (RR 3.22, 95% CI 0.13 to 78.13; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.7.14 Cardiorespiratory event (RR 0.15, 95% CI 0.01 to 2.93; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.7.15 Thromboembolic event (RR 0.21, 95% CI 0.01 to 4.42; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> <li> <p>3.7.16 Readmission or return to surgery due to postoperative complications (RR 0.15, 95% CI 0.01 to 2.93; 1 study, 228 women) (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>). </p> </li> </ul> </p> </section> <section id="CD000329-sec-0121"> <p><b>3.8 Adverse events: long term (after hospital discharge)</b></p> <p>One trial reported adverse events after hospital discharge (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). There was clear evidence of a difference in sepsis rate between the two groups favouring EA/ER compared to unspecified (or at surgeon's discretion) route of hysterectomy for sepsis after discharge (RR 0.27, 95% CI 0.13 to 0.58; 172 women; <a href="./references#CD000329-fig-0037" title="">Analysis 3.8</a>) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> <p>There was no clear evidence of a difference between groups after hospital discharge in terms of haematoma (RR 0.97, 95% CI 0.18 to 5.11; 172 women; <a href="./references#CD000329-fig-0037" title="">Analysis 3.8</a>) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> <p>There were no other adverse events reported.</p> </section> </section> </section> <section id="CD000329-sec-0122"> <h5 class="title">Secondary outcomes</h5> <section id="CD000329-sec-0123"> <h6 class="title">3.9 Duration of surgery</h6> <p>Two trials reported the duration of surgery (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). There was clear evidence of a difference between groups, being longer for unspecified (or at surgeon's discretion) route of hysterectomy, ranging between an MD of 16 and 31 minutes in each trial. This outcome presented a high heterogeneity (88%). Reasons for heterogeneity may have included skills of the surgeons, type of anaesthesia, characteristics of the women and the method used to record duration of the surgery (<a href="./references#CD000329-fig-0038" title="">Analysis 3.9</a>). </p> </section> <section id="CD000329-sec-0124"> <h6 class="title">3.10 Duration of hospital stay</h6> <p>Three trials evaluated duration of hospital stay (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). We were unable to pool the data due to extreme heterogeneity (100%). Despite this, all studies reported shorter hospital stays for EA compared to unspecified (or at surgeon's discretion) route of hysterectomy. Reasons for the heterogeneity may have included hospital protocols for discharge, geographic conditions and time when the trial took place (there was a clear difference in the time spent in hospital for hysterectomy in older trials compared to more recent ones). </p> </section> <section id="CD000329-sec-0125"> <h6 class="title">3.11 Time to return to normal activity</h6> <p>One trial reported time to return to normal activity (in days) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). There was clear evidence of a difference between groups favouring EA/ER compared to unspecified (or at surgeon's discretion) route of hysterectomy (MD –18.90 days, 95% CI –24.63 to –13.17; 172 women; low‐certainty evidence; <a href="./references#CD000329-fig-0040" title="">Analysis 3.11</a>) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </section> <section id="CD000329-sec-0126"> <h6 class="title">3.12 Time to return to work</h6> <p>One trial reported time to return to work (in weeks) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). There was clear evidence of a difference between groups favouring EA/ER compared to unspecified (or at surgeon's discretion) hysterectomy by four and a half weeks (MD –4.50 weeks, 95% CI –5.49 to –3.51; 172 women; <a href="./references#CD000329-fig-0041" title="">Analysis 3.12</a>) (<a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). </p> </section> <section id="CD000329-sec-0127"> <h6 class="title">3.13 Total health service cost per woman</h6> <p>One trial assessed the total health service cost per woman (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). There was clear evidence of a difference between groups favouring EA/ER for the management of HMB at short‐term follow‐up compared to unspecified (or at surgeon's discretion) route of hysterectomy (the costs of EA/ER were 76% to 80% of hysterectomy) (<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). This difference continued over a prolonged follow‐up time, but the cost gap narrowed primarily because of the retreatment rate for women who underwent endometrial resection. By four years, ablation techniques cost between 5% and 11% less than a hysterectomy (Aberdeen 1999/<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>) (<a href="./references#CD000329-fig-0042" title="">Analysis 3.13</a>). </p> </section> <section id="CD000329-sec-0128"> <h6 class="title">3.14 Total individual cost per woman</h6> <p>One trial measured costs to the women (Cameron 1996/<a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>). At one year' follow‐up, total personal costs, in terms of travel, loss of pay and child care, were higher for women who had a hysterectomy than for women who underwent EA/ER. However, women who had a hysterectomy estimated greater savings in the cost of sanitary protection when compared with those who underwent EA/ER(savings of GBP 85.10 per year with hysterectomy versus GBP 58.30 per year with EA/ER) (<a href="./references#CD000329-fig-0043" title="">Analysis 3.14</a>). </p> </section> </section> </section> <section id="CD000329-sec-0129"> <h4 class="title">Funnel plots</h4> <p>We were unable to include enough studies in the review for funnel plots to have sufficient power to distinguish chance from true asymmetry. </p> </section> <section id="CD000329-sec-0130"> <h4 class="title">Heterogeneity</h4> <p>We observed a high level of heterogeneity for some outcomes.</p> <p>For many outcomes, only one trial contributed data, and analysis of heterogeneity was not applicable. However, several or all studies contributed data for four outcomes and we visually inspected the forest plots for these outcomes. The estimate for proportion requiring further surgery showed a low level of heterogeneity (all CIs overlapping and I² = 0% at one and two years' follow‐up). However, there was a very high degree of heterogeneity evident for outcomes such as duration of surgery (I² = 99%), time to return to work (I² = 100%) and time to return to normal activities (I² = 97%). As discussed in each comparison the reasons could be multiple. </p> <p>All trials had similar risk profiles for most measures in the 'Risk of bias' table. Therefore, we assumed that there was no significant methodological heterogeneity present. </p> </section> <section id="CD000329-sec-0131"> <h4 class="title">Sensitivity analysis</h4> <p>We performed an analysis to investigate the effect of clear evidence of allocation concealment on effect estimates. For six of the eight trials, there was clear evidence that allocation was concealed, but for two trials (<a href="./references#CD000329-bbs2-0005" title="GannonMJ , HoltEM , FairbankJ , FitzgeraldM , MilneMA , CrystalAM , et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ (Clinical Research Ed.)1991;303(6814):1362-4. ">Gannon 1991</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), this was not the case. When we included only trials with clear evidence of allocation concealment in the meta‐analysis, there was no significant change in the estimates compared with inclusion of all trials for primary outcomes. </p> <p>We also performed an analysis to investigate the effect of missing data and loss to follow‐up on the effect estimates. Two of the included studies were at unclear risk of attrition bias (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0007" title="O'ConnorH , BroadbentJA , MagosAL , McPhersonK . Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet1997;349(9056):897-901. ">O'Connor 1997</a>). These trials contributed to most of the outcomes in Comparison 3 (EA/ER versus unspecified (or at surgeon's discretion) route of hysterectomy). When we included only trials that had a low risk of attrition bias and compared findings with the inclusion of all trials, we found no significant change in the estimates. For the outcomes, quality of life and satisfaction rates, there were only data from the trial(s) with unclear risk of attrition bias, so no comparison could be made. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000329-sec-0132" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000329-sec-0132"></div> <section id="CD000329-sec-0133"> <h3 class="title" id="CD000329-sec-0133">Summary of main results</h3> <p>This review assessed the benefits and harms of different surgical procedures for the treatment of HMB. In this 2020 update, we split the comparison of endometrial resection/ablation (EA/ER) versus hysterectomy into three separate comparisons; EA/ER versus open hysterectomy, EA/ER versus minimally invasive hysterectomy (laparoscopic and vaginal hysterectomy), and EA/ER versus unspecified (or at surgeon's discretion) route of hysterectomy. In the latter comparison, the included trials that did not specify the route of hysterectomy or the decision was left to the operator. This distinction was made as it is now clear that the safety profile, operating time and recovery times are individual to each surgical approach of hysterectomy and, therefore, the magnitude of the difference in these outcomes was likely to differ when each of these surgical approaches was compared against EA/ER (<a href="./references#CD000329-bbs2-0013" title="AartsJ , NieboerT , JohnsonN , TavenderE , GarryR , MolB . Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database of Systematic Reviews2015, Issue 8. Art. No: CD003677. [DOI: 10.1002/14651858.CD003677.pub5]">Aarts 2015</a>; <a href="./references#CD000329-bbs2-0029" title="GarryR , FountainJ , BrownJ , MancaA , MasonS , SculpherM , et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technology Assessment2005;8(26):1-154. [DOI: doi.org/10.3310/hta8260]">Garry 2005</a>). </p> <p><a href="./full#CD000329-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD000329-tbl-0002">summary of findings Table 2</a>; and <a href="./full#CD000329-tbl-0003">summary of findings Table 3</a> provide summaries of the results and the certainty of the evidence. </p> <p>All surgical procedures are effective in treating HMB as all reduced bleeding symptoms. However open, minimally invasive and unspecified (or at surgeon's discretion) hysterectomy all compared more favourably in terms of effectiveness than EA/ER. This was reflected in the more favourable outcomes for hysterectomy such as woman's perception of symptoms, PBAC scores and proportion requiring further surgery in all three comparisons. The indication for further surgery in the hysterectomy groups was very exceptional (being in one case because the woman received a treatment different to the one she was allocated to (EA/ER instead of hysterectomy) and in the other because it was a subtotal hysterectomy with persistent bleeding (as the uterine cervix remained in place). </p> <p>At most durations of follow‐up, regardless of how bleeding symptoms were measured, women in all the hysterectomy groups showed a greater reduction in symptoms than those in the EA/ER groups. For some outcomes, it was suggested that these differences were no longer experienced at longer durations of follow‐up; this might be due to several reasons including reduced numbers, retreatment in the EA/ER group and some women reaching menopause during the follow‐up period. </p> <p>In terms of quality of life, although there appeared to be some differences for various parameters of quality of life in diverse scales, there was no definitive evidence of an established pattern emerging, making it difficult to reach conclusions. The general health perception assessed using the SF‐36 at two years is probably better with the minimally invasive hysterectomy compared to the EA/ER group, but it may be similar between groups when open hysterectomy or the unspecified (or at surgeon's discretion) route of hysterectomy are compared to EA/ER. Women with minimally invasive hysterectomy probably have better quality‐of‐life scores when measured using the MMAS. </p> <p>The acceptability of the treatments, measured as the proportion satisfied with treatment at one year' follow‐up, is probably higher in the group having a minimally invasive hysterectomy compared to the EA/ER group, but it was probably similar when open hysterectomy or unspecified (or at surgeon's discretion) route of hysterectomy were compared to EA/ER. </p> <p>All the surgical approaches to hysterectomy and all methods of EA/ER can be regarded as safe, with low numbers of serious adverse events for all procedures. When adverse events (any serious) were considered, there was evidence of a difference between EA/ER versus open hysterectomy, or EA/ER versus minimally invasive hysterectomy. This may be because serious adverse events are rare. When EA/ER was compared against unspecified (or at surgeon's discretion) approach to hysterectomy for this outcome, the comparison favoured EA/ER. </p> <p>However, when considering individual adverse events, there were some clinically important differences. Open hysterectomy and unspecified (or at surgeon's discretion) hysterectomy were both associated with a higher chance of sepsis, pyrexia, wound infection, requirement for blood transfusion and vault haematoma, whereas there was no difference in these outcomes when comparing EA/ER against minimally invasive hysterectomy. This reflects findings from other publications that show a lower risk of infection and bleeding for minimally invasive hysterectomy than for open hysterectomy (<a href="./references#CD000329-bbs2-0041" title="MahdiH , GoodrichS , LockhartD , DeBernardoR , Moslemi-KebriaM . Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the National Surgical Quality Improvement Program data. Journal of Minimally Invasive Gynaecology2014;21(5):901-9.">Mahdi 2014</a>). </p> <p>Three trials reported that women in the EA/ER group were more likely to have fluid overload when compared against unspecified (or at surgeon's discretion) hysterectomy (<a href="./references#CD000329-bbs2-0003" title="DickersinK , MunroM , LangenbergP , SchererR , FrickKD , WeberAM , et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): design and methods. Controlled Clinical Trials2003;24(5):591-609. DickersinK , MunroMG , ClarkM , LangenbergP , SchererR , FrickK , et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstetrics and Gynecology2007;110(6):1279-89. MunroM , DickersonK , ClarkM , LangenbergP , SchererR , FrickK . The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause2011;18(4):451-8. ">Dickersin 2007</a>; <a href="./references#CD000329-bbs2-0008" title="Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology1999;106(4):360-6. AlexanderDA , NajiAA , PinionSB , MollisonJ , KitchenerHC , ParkinDE , et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (Clinical Research Ed.)1996;312(7026):280-4. CameronIM , MollisonJ , PinionSB , Atherton-NajiA , BuckinghamK , TorgersonD . A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. European Journal of Obstetrics and Gynaecology1996;70(1):87-92. PinionSB , ParkinDE , AbramovichDR , NajiA , AlexanderDA , RussellIT , et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (Clinical Research Ed.)1994;309(6960):979-83. ">Pinion 1994</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). This is less likely to be a risk with more modern EA techniques that do not require the use of a hypotonic fluid medium for uterine distension, and it is a risk only associated with EA/ER and not with hysterectomy. </p> <p>Although we were unable to pool the findings from the included studies due to high heterogeneity, almost all the individual trials consistently reported a shorter duration of surgery for EA/ER than hysterectomy in all three comparisons. Heterogeneity was highest in the minimally invasive hysterectomy versus EA/ER comparison, likely reflecting the longer learning curve required for laparoscopic hysterectomy, which was a novel technique at the time when some of these trials were undertaken. </p> <p>Similarly, duration of hospital stay revealed high levels of heterogeneity when EA/ER was compared against all three surgical approaches to hysterectomy. Duration of hospital stay was likely to be affected by changes outside the control of investigators in all trials. Hospital policy for maximum stay can vary significantly between hospitals and could have accounted for the heterogeneity observed in the results for this outcome. Many hospitals worldwide are adopting a policy of 'enhanced recovery' following elective surgery, including shorter times to discharge for major operations such as hysterectomy (by all surgical approaches). This high level of heterogeneity was most pronounced in the EA/ER versus minimally invasive hysterectomy comparison, and may reflect that one trial (<a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>) was much older than the other two trials (<a href="./references#CD000329-bbs2-0001" title="CooperK , BreemanS , ScottN , ScotlandG , ClarkJ , HaweJ , et al, on behalf of the HEALTH Study Group. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. Lancet2019;394(10207):1425-36. [DOI: dx.doi.org/10.1016/S0140-6736(19)31790-8]CooperK , McCormackK , BreemanS , WoodJ , ScottNW , ClarkJ , et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials2018;19(1):63. [DOI: doi.org/10.1186/s13063-017-2374-9]">Cooper 2019</a>; <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>), both of which showed a much smaller magnitude of difference in duration of hospital stay when compared against EA/ER than when open hysterectomy was compared against EA/ER. </p> <p>There were significant differences in time to return to normal activities and work in most of the trials, but the magnitude of these differences varied, depending on which mode of hysterectomy was being compared. The outcomes could not be pooled due to high heterogeneity. However, when compared against open hysterectomy or unspecified (or at surgeon's discretion) hysterectomy, the time to return to normal activity was clearly in favour of EA/ER, but when compared against minimally invasive hysterectomy, the difference was very small (1.5 days in <a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a> and 5 days in <a href="./references#CD000329-bbs2-0002" title="CrosignaniPG , VercelliniP , ApoloneG , De GiorgiO , CortesiI , MeschiaM . Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology1997;177(1):95-101. ">Crosignani 1997</a>). Similarly, the magnitude of difference in time to return to work was much smaller when comparing EA/ER versus minimally invasive hysterectomy than when comparing open or unspecified (or at surgeon's discretion) hysterectomy, and no different in one trial comparing EA/ER versus laparoscopic supracervical hysterectomy (<a href="./references#CD000329-bbs2-0010" title="CentiniG , LazzeriL , FincoA , AforsK , ZupiE . Quality of life and risk of reintervention comparing endometrial ablation and laparoscopic subtotal hysterectomy: a 15 years follow up study. Gynecological Surgery2015;12(Suppl 1):S11. ZupiE , CentiniG , LazzeriL , FincoA , ExacoustosC . Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomised trial. Journal of Minimally Invasive Gynecology2015;22(5):841-5. [DOI: 10.1016/j.jmig.2015.08.108]ZupiE , ZulloF , MarconiD , SbraciaM , PellicanoM , SolimaE , et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomised trial. American Journal of Obstetrics and Gynecology2003;188(1):7-12. ">Zupi 2003</a>). </p> <p>Evaluation of comparative costs between EA/ER and all surgical approaches to hysterectomy was affected by the increasing retreatment rate. Initially, treatment costs were much lower for women undergoing EA/ER than for those undergoing any surgical approach to hysterectomy, but the difference in costs between the groups narrowed over time because of the cost of retreatment. In one study with a minimum of four years' follow‐up, EA/ER was only 5% to 11% less costly than hysterectomy compared with 24% less costly at one year' follow‐up and 29% less costly at two years' follow‐up. Again 'enhanced recovery' policies may reflect a narrower difference in duration of hospital stay and, therefore, a corresponding narrower difference in patient costs. </p> <p>As described previously, outcomes may be altered by the prior experience of the surgeon for all surgical procedures. A less‐experienced surgeon for any treatment group could alter results such as duration of surgery, adverse outcomes and, in the case of EA/ER, effectiveness. </p> </section> <section id="CD000329-sec-0134"> <h3 class="title" id="CD000329-sec-0134">Overall completeness and applicability of evidence</h3> <p>The included studies adequately addressed the review question: to assess the relative effectiveness, acceptability and safety of any technique of EA/ER and hysterectomy via any route for the treatment of HMB, as well as the secondary outcomes. The inclusion and exclusion criteria were met, and the interventions well described. Unfortunately, the outcomes (particularly measures of improvement in bleeding symptoms) were measured in several different ways, and it was not possible for us to pool all estimates, making meta‐analysis impossible for some outcomes. </p> </section> <section id="CD000329-sec-0135"> <h3 class="title" id="CD000329-sec-0135">Quality of the evidence</h3> <p>This review update included 10 studies with 1966 randomly assigned participants.</p> <p>All studies were at high risk of performance/detection bias, as it is not feasible to blind women or surgeons to the type of operation that was performed. Several of the older studies were at high risk of selection bias. </p> <p>As the studies used many different measurements for the outcomes (particularly for effectiveness of treatment), it was not possible to pool data for every outcome. However, the results were largely comparable; both treatments were considered effective and safe, with the same rate of serious adverse events, hysterectomy was generally superior in improving symptoms and in leading to less requirement for future surgery, and EA/ER was superior in terms of shorter operating times and faster return to activities/work. </p> <p>For many outcomes, assessment of heterogeneity was not relevant, as only one trial contributed data. For outcomes that displayed a high level of clinical heterogeneity, this was explained in part by differences in outcomes for different modes of hysterectomy (further described under 'Sensitivity analysis'). </p> <p>Certainty of evidence was low to moderate, depending on the outcome. PBAC score, adverse events and proportion satisfied with treatment generated a moderate GRADE score, suggesting that further research may change the estimate. Outcomes that generated a low GRADE score included the PBAC score at one year' follow‐up and sepsis as an adverse event both for high risk of performance bias, and either imprecision or inconsistency. For these two outcomes, further evidence is likely to change the estimate. </p> </section> <section id="CD000329-sec-0136"> <h3 class="title" id="CD000329-sec-0136">Potential biases in the review process</h3> <p>Electronic searches in combination with handsearches performed by the review authors identified all relevant studies known to be available currently. Our inability to pool data for particular outcomes was likely to decrease the power of results; this may change if future studies are able to add data to the existing outcomes. </p> </section> <section id="CD000329-sec-0137"> <h3 class="title" id="CD000329-sec-0137">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD000329-bbs2-0017" title="BhattacharyaS , MiddletonL , TsourapasA , ChampaneriaR , DanielsJ , RobertsT , et al. Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technology Assessment2011;19:1-252.">Bhattacharya 2011</a> performed a systematic review that compared clinical‐effectiveness and cost‐effectiveness analyses of hysterectomy, EA/ER and levonorgestrel‐releasing intrauterine device (LNG‐IUS) for HMB. These findings were in accordance with the findings of this review; satisfaction rates at 12 months were highest for hysterectomy, and rates of further surgery after EA/ER were comparable (8.5%). The authors also noted longer hospital stay and longer time to return to normal activities for hysterectomy. </p> <p>Women who have undergone hysterectomy have experienced more postoperative complications than women who have received EA/ER, although for some types of complications, there were no differences. Because some complications are rare, these rates are best compared with those of large audits, such as the Mistletoe audit in the UK (<a href="./references#CD000329-bbs2-0047" title="OvertonC , HargreavesJ , MareshM . A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. British Journal of Obstetrics and Gynaecology1997;104(12):1351-9.">Overton 1997</a>). The low rate of complications for EA/ER in this review confirms the findings of the Mistletoe study. </p> <p>A comparison of costs of EA/ER techniques versus those of hysterectomy cannot adequately provide information on the relative value in terms of money of these two surgical procedures. The availability of EA/ER as a treatment for HMB may result in an earlier recourse to surgery than a woman would have considered if the only surgery available was hysterectomy (<a href="./references#CD000329-bbs2-0021" title="BridgmanSA . Increasing operative rates for dysfunctional uterine bleeding after endometrial ablation (letter). Lancet1994;344:893.">Bridgman 1994</a>; <a href="./references#CD000329-bbs2-0025" title="CoulterA . Trends in gynaecological surgery (letter). Lancet1994;344:1367.">Coulter 1994</a>), and this will have a significant impact on costs. Additional studies have provided assessments of cost‐effectiveness based on <a href="./references#CD000329-bbs2-0004" title="DwyerN , HuttonJ , StirratGM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):237-43. SculpherM . A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care1998;14(2):302-19. SculpherMJ , BryanS , DwyerN , HuttonJ , StirratGM . An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology1993;100(3):244-52. SculpherMJ , DwyerN , ByfordS , StirratGM . Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. British Journal of Obstetrics and Gynaecology1996;103(2):142-9. ">Dwyer 1993</a> through a cost‐utility analysis (<a href="./references#CD000329-bbs2-0051" title="SculpherM . The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia. Health Economics1998;7(2):129-42.">Sculpher 1998</a>); preference‐based treatment allocation (woman allocated to the treatment that she prefers) (<a href="./references#CD000329-bbs2-0051" title="SculpherM . The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia. Health Economics1998;7(2):129-42.">Sculpher 1998</a>); and four other cost‐utility analyses (<a href="./references#CD000329-bbs2-0022" title="CleggJP , GuestJF , HurskainenR . Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Current Medical Research and Opinion2007;23(7):1673-48.">Clegg 2007</a>; <a href="./references#CD000329-bbs2-0030" title="GarsideR , SteinK , WyattK , RoundA , PittM . A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. British Journal of Obstetrics and Gynaecology2004;111(10):1103-14.">Garside 2004</a>; <a href="./references#CD000329-bbs2-0049" title="RobertsT , TsourapasA , ChampaneriaR , DanielsJ , CooperK , BhattacharyaS , et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ2011;342:d2202.">Roberts 2011</a>; <a href="./references#CD000329-bbs2-0058" title="YouJH , SahotaDS , YuenPM . A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. Human Reproduction (Oxford, England)2006;21(7):1878-83.">You 2006</a>). <a href="./references#CD000329-bbs2-0030" title="GarsideR , SteinK , WyattK , RoundA , PittM . A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. British Journal of Obstetrics and Gynaecology2004;111(10):1103-14.">Garside 2004</a> concluded that abdominal hysterectomy is likely to be more cost‐effective than endometrial resection if healthcare purchasers are willing to pay an additional cost of at least GBP 6500 per extra quality‐adjusted life‐year (QALY) generated by hysterectomy, although an area of uncertainty is attached to this conclusion in the form of variation in the parameters used in the analysis. <a href="./references#CD000329-bbs2-0022" title="CleggJP , GuestJF , HurskainenR . Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Current Medical Research and Opinion2007;23(7):1673-48.">Clegg 2007</a> found that a preference‐based treatment allocation was more cost‐effective than reliance on a single intervention for all women requiring surgery for HMB. <a href="./references#CD000329-bbs2-0030" title="GarsideR , SteinK , WyattK , RoundA , PittM . A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. British Journal of Obstetrics and Gynaecology2004;111(10):1103-14.">Garside 2004</a> reported that hysterectomy was more expensive than EA but accrued more QALYs over 10 years. The incremental cost per QALY of hysterectomy compared with two second‐generation EA techniques was approximately GBP 2000. <a href="./references#CD000329-bbs2-0058" title="YouJH , SahotaDS , YuenPM . A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. Human Reproduction (Oxford, England)2006;21(7):1878-83.">You 2006</a> also confirmed that hysterectomy was a more expensive option than EA (cost per woman: USD 6878 with hysterectomy versus USD 6185 with EA over five years) but was more effective (4.725 QALYs with hysterectomy versus 4.624 QALYs with EA). <a href="./references#CD000329-bbs2-0049" title="RobertsT , TsourapasA , ChampaneriaR , DanielsJ , CooperK , BhattacharyaS , et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ2011;342:d2202.">Roberts 2011</a> found that hysterectomy produced more QALYs relative to second‐generation EA, with an incremental cost‐effectiveness ratio of GBP 970 per additional QALY. Data from a cost‐utility analysis in <a href="./references#CD000329-bbs2-0022" title="CleggJP , GuestJF , HurskainenR . Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Current Medical Research and Opinion2007;23(7):1673-48.">Clegg 2007</a> contradicted this finding: the authors reported that second‐generation EA accrued marginally more QALYs than hysterectomy over five years (4.13 with EA versus 4.01 QALYs with hysterectomy). Evaluation of the comparative cost‐effectiveness of endometrial destruction techniques and hysterectomy is complex, and the simple conclusion that endometrial destruction is cheaper than hysterectomy, with the difference narrowing over time, may not represent an adequate economic assessment. </p> <p>Overall, the review findings were consistent with currently accepted clinical advice and agree with current guidelines. National Institute for Health and Care Excellence (NICE) guidelines for menorrhagia suggest that hysterectomy should not be used as a first‐line treatment for benign HMB and should be considered only when other treatment options have failed, are contraindicated or are declined by the woman; when there is a wish for amenorrhoea; when the woman (who has been fully informed) requests it; when the woman no longer wishes to retain her uterus and fertility; or a combination of these (<a href="./references#CD000329-bbs2-0045" title="National Collaborating Centre for Women's and Children's Health. Heavy Menstrual Bleeding. London: RCOG Press, 2007.">NICE 2007</a>; <a href="./references#CD000329-bbs2-0046" title="NICE guideline. Heavy menstrual bleeding: assessment and management. www.nice.org.uk/guidance/ng88 (accessed prior to 21 January 2020).">NICE 2018</a>). <a href="./references#CD000329-bbs2-0045" title="National Collaborating Centre for Women's and Children's Health. Heavy Menstrual Bleeding. London: RCOG Press, 2007.">NICE 2007</a> and <a href="./references#CD000329-bbs2-0046" title="NICE guideline. Heavy menstrual bleeding: assessment and management. www.nice.org.uk/guidance/ng88 (accessed prior to 21 January 2020).">NICE 2018</a> guidelines are in agreement with the findings of this review with regard to potential complications associated with both modes of surgical treatment. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000329-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study screening and selection process (2018 to 2020)." data-id="CD000329-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study screening and selection process (2018 to 2020).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD000329-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000329-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms)" data-id="CD000329-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 2: Quality‐of‐life scores (continuous data)" data-id="CD000329-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 2: Quality‐of‐life scores (continuous data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 3: Quality of life (proportion with improvement)" data-id="CD000329-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 3: Quality of life (proportion with improvement) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 4: Requirement for further surgery for treatment failure" data-id="CD000329-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 4: Requirement for further surgery for treatment failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 5: Proportion satisfied with treatment" data-id="CD000329-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 5: Proportion satisfied with treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 6: Any serious adverse event" data-id="CD000329-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 6: Any serious adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 7: Adverse events – short term (intraoperative and immediate postoperative)" data-id="CD000329-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 7: Adverse events – short term (intraoperative and immediate postoperative) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 8: Adverse events – long term (after hospital discharge)" data-id="CD000329-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 8: Adverse events – long term (after hospital discharge) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 9: Duration of surgery (minutes)" data-id="CD000329-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 9: Duration of surgery (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 10: Duration of hospital stay (days)" data-id="CD000329-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 10: Duration of hospital stay (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 11: Time to return to normal activity (days)" data-id="CD000329-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 11: Time to return to normal activity (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 12: Time to return to work (weeks)" data-id="CD000329-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 12: Time to return to work (weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0016"> <p> <div class="table" id="CD000329-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Total health service cost per woman</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Details</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Dwyer 1993</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Four months' follow‐up</b> </p> <p>Mean resource cost per participant in 1991/1992 prices:</p> <p> <ul id="CD000329-list-0036"> <li> <p>Endometrial resection: GBP 560.05 (standard deviation (SD) 261.22);</p> </li> <li> <p>Hysterectomy: GBP 1059.73 (SD 198.04).</p> </li> </ul> </p> <p>These costs were made up of preoperative, operative and postoperative costs; hotel costs; complications costs; retreatment and general practice costs. </p> <p>Mean difference in cost between groups: GBP –499.68 (95% confidence interval (CI) –567 to –432) </p> <p>Statistical test not specifically stated.</p> <p>Mean cost of resection at 4 months' follow‐up 53% of the cost of hysterectomy.</p> <p><b>2.2 years' follow‐up</b> </p> <p>Mean resource cost per participant in 1994 prices:</p> <p> <ul id="CD000329-list-0037"> <li> <p>Endometrial resection: GBP 790 (SD 493)</p> </li> <li> <p>Hysterectomy: GBP 1110 (SD 168)</p> </li> </ul> </p> <p>Costs made up of initial surgery, retreatment costs, other resource use after 4 months and hormone replacement therapy. </p> <p>Wilcoxon Rank Sum test used to test the difference between groups with a 5% significance level, P = 0.0001. </p> <p>Mean cost of resection at 2.2 years' follow‐up 71% of the cost of hysterectomy.</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Gannon 1991</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Initial costs (NHS)</b> </p> <p>Mean cost per operation in 1991:</p> <p> <ul id="CD000329-list-0038"> <li> <p>Endometrial resection: GBP 407</p> </li> <li> <p>Abdominal hysterectomy: GBP 1270</p> </li> </ul> </p> <p>This cost was made up of: variable costs: mean cost of theatre consumables, staffing and maintenance in the operating theatre, marginal cost of a bed on the gynaecological ward; and fixed costs: capital depreciation, hospital staffing and energy. </p> <p>The difference between groups in resource cost was not assessed in a statistical test.</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Endometrial resection/ablation versus open hysterectomy, Outcome 13: Total health service cost per woman </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0016">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000329-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms)" data-id="CD000329-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 2: PBAC score (continuous data)" data-id="CD000329-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 2: PBAC score (continuous data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 3: Quality‐of‐life scores (continuous data)" data-id="CD000329-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 3: Quality‐of‐life scores (continuous data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 4: Proportion with MMAS = 100 (best possible) 15 months after randomisation" data-id="CD000329-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 4: Proportion with MMAS = 100 (best possible) 15 months after randomisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0021"> <p> <div class="table" id="CD000329-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Quality of life at 14 years' follow‐up</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Hysterectomy group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Endometrial ablation group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Zupi 2003</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical score ranged from 57.5 to 51.4</p> <p>Mental score ranged from 56.8 to 50.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical score ranged from 55.04 to 45.4</p> <p>Mental score ranged from 51.9 to 36.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The difference was significant for both parameters physical and mental score. P &lt; 0.0001 </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 5: Quality of life at 14 years' follow‐up </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0021">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000329-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 6: Requirement for further surgery for treatment failure" data-id="CD000329-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 6: Requirement for further surgery for treatment failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 7: Proportion satisfied with treatment" data-id="CD000329-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 7: Proportion satisfied with treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 8: Any serious adverse event" data-id="CD000329-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 8: Any serious adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 9: Adverse events – short term (intraoperative and immediate postoperative)" data-id="CD000329-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 9: Adverse events – short term (intraoperative and immediate postoperative) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 10: Duration of surgery (minutes)" data-id="CD000329-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 10: Duration of surgery (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 11: Duration of hospital stay (days)" data-id="CD000329-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 11: Duration of hospital stay (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 12: Time to return to normal activity (days)" data-id="CD000329-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 12: Time to return to normal activity (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 13: Time to return to work (weeks)" data-id="CD000329-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: Endometrial resection/ablation versus minimally invasive hysterectomy, Outcome 13: Time to return to work (weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms)" data-id="CD000329-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 1: Woman's perception (proportion with improvement in bleeding symptoms) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 2: Quality‐of‐life scores (continuous data)" data-id="CD000329-fig-0031" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 2: Quality‐of‐life scores (continuous data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 3: Quality of life (proportion with improvement)" data-id="CD000329-fig-0032" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 3: Quality of life (proportion with improvement) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 4: Requirement for further surgery for treatment failure" data-id="CD000329-fig-0033" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 4: Requirement for further surgery for treatment failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 5: Proportion satisfied with treatment" data-id="CD000329-fig-0034" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 5: Proportion satisfied with treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 6: Any serious adverse event" data-id="CD000329-fig-0035" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 6: Any serious adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 7: Adverse events – short term (intraoperative and immediate postoperative)" data-id="CD000329-fig-0036" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 7: Adverse events – short term (intraoperative and immediate postoperative) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 8: Adverse events – long term (after hospital discharge)" data-id="CD000329-fig-0037" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 8: Adverse events – long term (after hospital discharge) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 9: Duration of surgery (minutes)" data-id="CD000329-fig-0038" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 9: Duration of surgery (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 10: Duration of hospital stay (days)" data-id="CD000329-fig-0039" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 10: Duration of hospital stay (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 11: Time to return to normal activity (days)" data-id="CD000329-fig-0040" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 11: Time to return to normal activity (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/urn:x-wiley:14651858:media:CD000329:CD000329-CMP-003.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 12: Time to return to work (weeks)" data-id="CD000329-fig-0041" src="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_t/tCD000329-CMP-003.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 12: Time to return to work (weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/media/CDSR/CD000329/image_n/nCD000329-CMP-003.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000329-fig-0042"> <p> <div class="table" id="CD000329-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Total health service cost per woman</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Details</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Pinion 1994</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 year' follow‐up</b> </p> <p>Mean resource cost per participant in 1994:</p> <p> <ul id="CD000329-list-0039"> <li> <p>Endometrial resection: GBP 1001.00;</p> </li> <li> <p>Laser ablation: GBP 1046.00;</p> </li> <li> <p>Hysterectomy: GBP 1315.00.</p> </li> </ul> </p> <p>No statistical test used to compare the difference between groups.</p> <p>Mean cost of endometrial resection at 1 year' follow‐up was 76% of the cost of hysterectomy.</p> <p>Mean cost of laser ablation at 1 year' follow‐up was 80% of the cost of hysterectomy.</p> <p>Costs based on preoperative costs, nights in hospital, theatre and ward costs, general practitioner and outpatient costs, retreatment costs and technical equipment costs. </p> <p><b>4 years' follow‐up</b> </p> <p>Mean resource cost per patient in 1994:</p> <p> <ul id="CD000329-list-0040"> <li> <p>Endometrial destruction techniques: GBP 1231;</p> </li> <li> <p>Hysterectomy: GBP 1332.</p> </li> </ul> </p> <p>Included additional costs for retreatment or additional procedures arising between 1 and 4 years after surgery. Data reported as 1994 rates (discounted by 6%). </p> <p>Sensitivity analysis performed with variations in the discount rate.</p> <p>Cost of endometrial ablation techniques at 4 years reported as between 89% and 95% the costs of hysterectomy. </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 13: Total health service cost per woman </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0042">Navigate to figure in review</a></div> </div> <div class="figure" id="CD000329-fig-0043"> <p> <div class="table" id="CD000329-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Total individual cost per woman</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Details</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Pinion 1994</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 year' follow‐up</b> </p> <p>Mean patient cost in in 1994:</p> <p> <ul id="CD000329-list-0041"> <li> <p>Hysteroscopic surgery: GBP 21.00 (95% confidence interval (CI) 13.3 to 33.1);</p> </li> <li> <p>Hysterectomy: GBP 73.40 (95% CI 42.1 to 127).</p> </li> </ul> </p> <p>Mean cost of hysteroscopic surgery was 29% the cost of hysterectomy.</p> <p>Costs estimated included loss of pay, child care and travel expenses.</p> <p>Student t test used to compare differences between surgery groups, P &lt; 0.05.</p> <p>Mean annual savings from sanitary protection after treatment in 1994:</p> <p> <ul id="CD000329-list-0042"> <li> <p>Hysteroscopic surgery: GBP 58.30 (95% CI 51.4 to 66);</p> </li> <li> <p>Hysterectomy: GBP 85.10 (95% CI 72.2 to 100).</p> </li> </ul> </p> <p>Student t test used to compare differences between surgery groups, P &lt; 0.05.</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3: Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy, Outcome 14: Total individual cost per woman </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-fig-0043">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000329-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endometrial resection or ablation compared to open hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to open hysterectomy for HMB</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> HMB<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> open hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with open hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effectiveness</b> </p> <p><b>Woman's perception (proportion with improvement in bleeding symptoms)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>900 per 1000<br/>(840 to 950) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b><br/>(0.84 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life SF‐36 at 2 years</b> – <b>general health perception</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (SF‐36, 2 years) general health perception was 74</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.3 lower</b><br/>(11.9 lower to 1.3 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure within 1 year after surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Risk of having additional surgery in the EA group was 12.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The open hysterectomy (total) has no risk of further surgery for HMB (structural 0).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>937 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>853 per 1000<br/>(768 to 937) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b><br/>(0.82 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/>(8 to 127) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.29</b><br/>(0.32 to 5.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to return to normal activity was 28 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 21 days lower</b><br/>(24.78 lower to 17.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>EA:</b> endometrial ablation; <b>HMB:</b> heavy menstrual bleeding; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (performance).<br/><sup>b</sup>Downgraded one level for inconsistency. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endometrial resection or ablation compared to open hysterectomy for heavy menstrual bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000329-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endometrial resection or ablation versus minimally invasive hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to minimally invasive hysterectomy for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> heavy menstrual bleeding<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> minimally invasive hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with minimally invasive hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Effectiveness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion of women with perception of improvement in bleeding symptoms</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>970 per 1000<br/>(900 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b><br/>(0.90 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PBAC score</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PBAC score (continuous data) ‐</p> <p>At 2 years' follow‐up was 29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 44 higher</b><br/>(36.09 higher to 51.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SF‐36 general health perception</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (continuous data) –</p> <p>SF‐36 at 2 years – general health perception was 77.48</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 10.71 lower</b><br/>(15.11 lower to 6.3 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion with MMAS</b> = 100 (best possible) </p> <p>15 months after randomisations</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>583 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>478 per 1000<br/>(408 to 553) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.82</b><br/>(0.70 to 0.95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>616<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure within 1 year after surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(11 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 7.70</b><br/>(2.54 to 23.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>922<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>971 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>874 per 1000<br/>(826 to 913) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b><br/>(0.85 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>558<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/>(13 to 59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b><br/>(0.35 to 1.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>809<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>We were unable to pool data because of extreme heterogeneity (99%).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MMAS:</b> Menorrhagia Multi‐Attribute Scale; <b>PBAC:</b> Pictorial Blood Loss Assessment Chart; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision. One small trial.<br/><sup>b</sup>Downgraded one level for risk of bias (performance). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endometrial resection or ablation versus minimally invasive hysterectomy for heavy menstrual bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000329-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy for heavy menstrual bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endometrial resection/ablation compared to unspecified (or at surgeon's discretion) hysterectomy for heavy menstrual bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> heavy menstrual bleeding<br/><b>Setting:</b> clinic<br/><b>Intervention:</b> endometrial resection/ablation<br/><b>Comparison:</b> surgeon's choice of route of hysterectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with unspecified (or at surgeon's discretion) hysterectomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with endometrial resection/ablation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effectiveness</b> </p> <p><b>Proportion of women with perception of improvement of bleeding symptoms</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>965 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>859 per 1000<br/>(801 to 917) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b><br/>(0.83 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>403<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p><b>SF‐36 general health perception</b> </p> <p>Follow‐up: 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality‐of‐life scores (continuous data)</p> <p>– SF‐36 at 1 year –</p> <p>general health perception was 66.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.9 lower</b><br/>(8.67 lower to 4.87 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score reflects better quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Proportion with improvement in general health</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>955 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>812 per 1.000<br/>(735 to 907) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b><br/>(0.77 to 0.95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>185<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Requirement for further surgery for treatment failure</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Risk of having additional surgery in the endometrial resection/ablation group was 5.4% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total hysterectomy has no risk of further surgery for treatment failure (structural 0). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acceptability</b> </p> <p><b>Proportion satisfied with treatment</b> </p> <p>Follow‐up: 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>773 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>742 per 1000<br/>(680 to 804) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b><br/>(0.88 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>545<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Safety</b> </p> <p><b>Any serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/>(4 to 47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.21</b><br/>(0.06 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to return to normal activity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to return to normal activity was 32 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 18.9 days lower</b><br/>(24.63 lower to 13.17 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias (performance).<br/><sup>b</sup>Downgraded one level for inconsistency, as it may present substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy for heavy menstrual bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/full#CD000329-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000329-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endometrial resection/ablation versus open hysterectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Woman's perception (proportion with improvement in bleeding symptoms) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.84, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Within 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.84, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Quality‐of‐life scores (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 SF‐36 at 2 years – pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.90 [‐17.63, ‐2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 SF‐36 at 2 years – general health perception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.30 [‐11.90, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 SF‐36 at 2 years – role limitation (physical)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐9.82, 11.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 SF‐36 at 2 years – role limitation (emotional)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.20 [‐15.87, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.5 SF‐36 at 2 years – social functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.00 [‐12.11, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.6 SF‐36 at 2 years – mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.49, 2.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.7 SF‐36 at 2 years – energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐8.18, 5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.8 SF‐36 at 2 years – physical functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐7.56, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.9 EuroQol score within 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.00 [‐17.29, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.10 EuroQol scores at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐6.29, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Quality of life (proportion with improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Proportion with improvement in pain 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.55, 4.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Requirement for further surgery for treatment failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Within 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.03 [2.29, 126.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 At 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>63.70 [3.96, 1025.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Proportion satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 At 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.82, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Any serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.32, 5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Adverse events – short term (intraoperative and immediate postoperative) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.02, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Pyrexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.02, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.3 Vault haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.03, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.4 Blood transfusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Adverse events – long term (after hospital discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.94 [0.12, 71.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Duration of surgery (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Duration of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Time to return to normal activity (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Time to return to work (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.72 [‐8.05, ‐7.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Total health service cost per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endometrial resection/ablation versus open hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000329-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Endometrial resection/ablation versus minimally invasive hysterectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Woman's perception (proportion with improvement in bleeding symptoms) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 PBAC score (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 At 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>24.40 [16.01, 32.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>44.00 [36.09, 51.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Quality‐of‐life scores (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 SF‐36 at 1 year – social functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.20 [‐24.73, ‐17.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 SF‐36 at 1 year – energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.30 [‐14.82, ‐7.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 SF‐36 at 1 year – general health perception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.80 [‐13.86, ‐5.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.4 SF‐36 at 2 years – social functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.02 [‐16.26, ‐7.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.5 SF‐36 at 2 years – general health perception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.71 [‐15.11, ‐6.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.6 SF‐36 at 2 years – pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.68 [‐17.09, ‐8.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.7 SF‐36 at 2 years – physical functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.59 [‐20.47, ‐10.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.8 SF‐36 at 2 years – role limitation (emotional)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.41 [9.97, 20.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.9 SF‐36 at 2 years – mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.72 [4.30, 13.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.10 SF‐36 at 1 year – role limitation (physical)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐4.99, 3.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.11 SF‐36 at 1 year – role limitation (emotional)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.90 [‐8.21, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.12 SF‐36 at 1 year – mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.70 [‐6.84, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.13 SF‐36 at 1 year – pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐6.05, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.14 SF‐36 at 1 year – physical functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐5.34, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.15 SF‐36 at 2 years – energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.49 [‐0.36, 9.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.16 SF‐36 at 2 years – role limitation (physical)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.12 [‐9.58, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.17 SSR score at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.70 [‐11.17, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.18 Total HADS score at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐4.32, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.19 Anxiety HADS score at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐3.28, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.20 Depression HADS score at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.28, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.21 SF‐12 physical score at 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐2.78, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.22 SF‐12 mental score at 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐4.00, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Proportion with MMAS = 100 (best possible) 15 months after randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Quality of life at 14 years' follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Requirement for further surgery for treatment failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Within 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>922</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.70 [2.54, 23.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 At 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.75 [2.24, 125.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.3 At 14 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.60 [1.15, 333.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Proportion satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 At 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.85, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.79, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Any serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.35, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Adverse events – short term (intraoperative and immediate postoperative) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.29, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Blood transfusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>837</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.11, 4.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.3 Pyrexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.24, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.4 Vault haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.5 Fluid overload</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.37 [0.64, 202.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.6 Haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.27, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.7 Perforation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.02 [0.32, 28.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.8 Laparotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.05, 5.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.9 Cystotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.10 Cervical laceration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.13, 75.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Duration of surgery (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Duration of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Time to return to normal activity (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 Time to return to work (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Endometrial resection/ablation versus minimally invasive hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000329-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Woman's perception (proportion with improvement in bleeding symptoms) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Within 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.83, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.82, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 At 4 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.88, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Quality‐of‐life scores (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 SF‐36 at 1 year – mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [‐5.17, 8.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 SF‐36 at 1 year – energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐20.90, 16.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 SF‐36 at 1 year – pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐9.53, 3.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.4 SF‐36 at 1 year – general health perception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐7.24, 5.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.5 SF‐36 at 2 years – pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐8.86, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.6 SF‐36 at 2 years – general health perception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐8.67, 4.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.7 SF‐36 at 2 years – energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.60 [‐22.47, ‐8.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.8 GR inventory scores at 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐1.75, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.9 EuroQol score within 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐7.90, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.10 EuroQol scores at 2 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐8.20, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.11 Anxiety HADS scores at 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.39, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.12 Depression HADS scores at 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.09, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Quality of life (proportion with improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Proportion with improvement in general health 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.77, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Proportion with improvement in general health 4 years after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.80, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Requirement for further surgery for treatment failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Within 1 year after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.19 [4.25, 187.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>35.70 [5.30, 240.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.3 At 3 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>22.90 [1.42, 370.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.4 At 4 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>73.63 [4.59, 1181.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Proportion satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 At 1 year' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>545</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.88, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 At 2 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.3 At 4 years' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Any serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.06, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Adverse events – short term (intraoperative and immediate postoperative) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 Sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.17, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.2 Blood transfusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.3 Pyrexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.08, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.4 Vault haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.02, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.5 Wound haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.6 Fluid overload</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.59 [1.59, 46.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.7 Haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.24, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.8 Anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 3.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.9 Perforation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.05 [0.61, 42.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.10 Gastrointestinal obstruction/ileus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.04, 5.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.11 Laparotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.12 Cystotomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.13 Cervical laceration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.22 [0.13, 78.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.14 Cardiorespiratory event</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.15 Thromboembolic event</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.16 Readmission/return to surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Adverse events – long term (after hospital discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.1 Sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.13, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.2 Haematoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.18, 5.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 Duration of surgery (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.73 [‐24.35, ‐15.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.10 Duration of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.11 Time to return to normal activity (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.12 Time to return to work (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.13 Total health service cost per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.14 Total individual cost per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Endometrial resection/ablation versus unspecified (or at surgeon's discretion) route of hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000329.pub4/references#CD000329-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000329.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000329-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000329-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000329-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000329-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD000329-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD000329-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD000329-note-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000329-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000329\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000329\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000329\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000329\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000329\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000329.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000329.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000329.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000329.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000329.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718213594"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000329.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718213598"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000329.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcadc0d0ef3fd',t:'MTc0MDcxODIxMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 